BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front Immunol. 2020;11:1446. [PMID: 32612617 DOI: 10.3389/fimmu.2020.01446] [Cited by in Crossref: 330] [Cited by in F6Publishing: 323] [Article Influence: 165.0] [Reference Citation Analysis]
Number Citing Articles
1 Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S, On Behalf Of Task Force Covid-Collège National des EnseignantS En Biologie Orale Cnesbo-France. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature. J Clin Med 2021;10:779. [PMID: 33669185 DOI: 10.3390/jcm10040779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Fogante M, Cavagna E, Rinaldi G. Coronary arteries and aortic valve calcifications in COVID-19. Emerg Radiol. [DOI: 10.1007/s10140-021-02011-3] [Reference Citation Analysis]
3 Mishra KP, Singh M, Saraswat D, Ganju L, Varshney R. Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review. Viral Immunol 2022. [PMID: 35325564 DOI: 10.1089/vim.2022.0002] [Reference Citation Analysis]
4 Barrea L, Vetrani C, Caprio M, Cataldi M, Ghoch ME, Elce A, Camajani E, Verde L, Savastano S, Colao A, Muscogiuri G. From the Ketogenic Diet to the Mediterranean Diet: The Potential Dietary Therapy in Patients with Obesity after CoVID-19 Infection (Post CoVID Syndrome). Curr Obes Rep 2022. [PMID: 35524067 DOI: 10.1007/s13679-022-00475-z] [Reference Citation Analysis]
5 Pinzón MA, Ortiz S, Holguín H, Betancur JF, Cardona Arango D, Laniado H, Arias Arias C, Muñoz B, Quiceno J, Jaramillo D, Ramirez Z. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia. PLoS One 2021;16:e0252057. [PMID: 34033648 DOI: 10.1371/journal.pone.0252057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Khaled JMA. Probiotics, prebiotics, and COVID-19 infection: A review article. Saudi J Biol Sci 2021;28:865-9. [PMID: 33424377 DOI: 10.1016/j.sjbs.2020.11.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Basin S, Valentin S, Maurac A, Poussel M, Pequignot B, Brindel A, Poupet G, Robert C, Baumann C, Luc A, Soler J, Chabot F, Chaouat A. Progression to a severe form of COVID-19 among patients with chronic respiratory diseases. Respir Med Res 2021;81:100880. [PMID: 34974204 DOI: 10.1016/j.resmer.2021.100880] [Reference Citation Analysis]
8 Karampoor S, Hesamizadeh K, Maleki F, Farahmand M, Zahednasab H, Mirzaei R, Banoun H, Zamani F, Hajibaba M, Tabibzadeh A, Bouzari B, Bastani MN, Laali A, Keyvani H. A possible pathogenic correlation between neutrophil elastase (NE) enzyme and inflammation in the pathogenesis of coronavirus disease 2019 (COVID-19). Int Immunopharmacol 2021;100:108137. [PMID: 34536744 DOI: 10.1016/j.intimp.2021.108137] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 McDonald LT. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol 2021;320:L257-65. [PMID: 33355522 DOI: 10.1152/ajplung.00238.2020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
10 Situmeang RFV, Stevano R, Sutanto R. COVID-19 as a trigger of cerebral venous sinus thrombosis in a patient with autoimmune hyperthyroidism: a case report. Egypt J Neurol Psychiatry Neurosurg 2022;58. [DOI: 10.1186/s41983-022-00476-8] [Reference Citation Analysis]
11 Hussain I, Cher GLY, Abid MA, Abid MB. Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential. Front Immunol 2021;12:765965. [PMID: 34721437 DOI: 10.3389/fimmu.2021.765965] [Reference Citation Analysis]
12 Pinheiro MM, Fabbri A, Infante M. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy 2021;13:753-65. [PMID: 33906375 DOI: 10.2217/imt-2020-0349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Al-Kuraishy HM, Al-Gareeb AI, Abdullah SM, Cruz-Martins N, Batiha GE. Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances. Front Cardiovasc Med 2021;8:642181. [PMID: 33681310 DOI: 10.3389/fcvm.2021.642181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Plowman T, Lagos D. Non-Coding RNAs in COVID-19: Emerging Insights and Current Questions. Noncoding RNA 2021;7:54. [PMID: 34564316 DOI: 10.3390/ncrna7030054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Conti V, Corbi G, Sellitto C, Sabbatino F, Maci C, Bertini N, De Bellis E, Iuliano A, Davinelli S, Pagliano P, Filippelli A. Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis. J Pers Med 2021;11:628. [PMID: 34357095 DOI: 10.3390/jpm11070628] [Reference Citation Analysis]
16 Chen P, Tang Y, He W, Yang R, Lan Z, Chen R, Zhang P, Yokota S. Potential Pathophysiological Mechanisms Underlying Multiple Organ Dysfunction in Cytokine Release Syndrome. Mediators of Inflammation 2022;2022:1-17. [DOI: 10.1155/2022/7137900] [Reference Citation Analysis]
17 Saha RP, Sharma AR, Singh MK, Samanta S, Bhakta S, Mandal S, Bhattacharya M, Lee SS, Chakraborty C. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19. Front Pharmacol. 2020;11:1258. [PMID: 32973505 DOI: 10.3389/fphar.2020.01258] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 20.5] [Reference Citation Analysis]
18 Liu H, Yang D, Chen X, Sun Z, Zou Y, Chen C, Sun S. The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis. Cancer Med 2021;10:1043-56. [PMID: 33381923 DOI: 10.1002/cam4.3692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Tabassum T, Rahman A, Araf Y, Ullah MA, Hosen MJ. Prospective selected biomarkers in COVID-19 diagnosis and treatment. Biomark Med 2021;15:1435-49. [PMID: 34538093 DOI: 10.2217/bmm-2021-0038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Rodrigues PRS, Alrubayyi A, Pring E, Bart VMT, Jones R, Coveney C, Lu F, Tellier M, Maleki-Toyserkani S, Richter FC, Scourfield DO, Gea-Mallorquí E, Davies LC. Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology. Oxf Open Immunol 2020;1:iqaa005. [PMID: 34192268 DOI: 10.1093/oxfimm/iqaa005] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Djuricic I, Calder PC. Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021. Nutrients 2021;13:2421. [PMID: 34371930 DOI: 10.3390/nu13072421] [Reference Citation Analysis]
22 Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi RKS, Schreiner P, Neale G, Vogel P, Webby R, Jonsson CB, Kanneganti TD. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. bioRxiv 2020:2020. [PMID: 33140051 DOI: 10.1101/2020.10.29.361048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
23 E Costa RAP, Granato DC, Trino LD, Yokoo S, Carnielli CM, Kawahara R, Domingues RR, Pauletti BA, Neves LX, Santana AG, Paulo JA, Aragão AZB, Heleno Batista FA, Migliorini Figueira AC, Laurindo FRM, Fernandes D, Hansen HP, Squina F, Gygi SP, Paes Leme AF. ADAM17 cytoplasmic domain modulates Thioredoxin-1 conformation and activity. Redox Biol 2020;37:101735. [PMID: 33011677 DOI: 10.1016/j.redox.2020.101735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kusi KA, Frimpong A, Partey FD, Lamptey H, Amoah LE, Ofori MF. High infectious disease burden as a basis for the observed high frequency of asymptomatic SARS-CoV-2 infections in sub-Saharan Africa. AAS Open Res 2021;4:2. [DOI: 10.12688/aasopenres.13196.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Ernzen K, Trask AJ, Peeples ME, Garg V, Zhao MT. Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System. Stem Cell Rev Rep 2021. [PMID: 34365591 DOI: 10.1007/s12015-021-10229-4] [Reference Citation Analysis]
26 Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi RKS, Schreiner P, Neale G, Vogel P, Webby R, Jonsson CB, Kanneganti TD. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes. Cell 2021;184:149-168.e17. [PMID: 33278357 DOI: 10.1016/j.cell.2020.11.025] [Cited by in Crossref: 131] [Cited by in F6Publishing: 124] [Article Influence: 65.5] [Reference Citation Analysis]
27 Baeten P, Van Zeebroeck L, Kleinewietfeld M, Hellings N, Broux B. Improving the Efficacy of Regulatory T Cell Therapy. Clin Rev Allergy Immunol 2021. [PMID: 34224053 DOI: 10.1007/s12016-021-08866-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Du X, Shi L, Cao W, Zuo B, Zhou A. Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: A systematic review and meta-analysis. PLoS One 2021;16:e0256429. [PMID: 34415962 DOI: 10.1371/journal.pone.0256429] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Pecetta S, Kratochvil S, Kato Y, Vadivelu K, Rappuoli R. Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines. Pharmacol Rev 2022;74:313-39. [PMID: 35101964 DOI: 10.1124/pharmrev.120.000285] [Reference Citation Analysis]
30 McGrath R, Carson PJ, Jurivich DA. Letter to the editor: It is Important to Examine Physical Functioning and Inflammatory Responses During Post-Hospitalization COVID-19 Recovery. J Frailty Aging 2021;10:301-2. [PMID: 34105717 DOI: 10.14283/jfa.2020.73] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Chopra S, Saha A, Kumar V, Thakur A, Pemde H, Kapoor D, Ray S, Das A, Pandit K, Gulati A, Sharma AG, Singh P, Sodani R. Acute Kidney Injury in Hospitalized Children with COVID19. J Trop Pediatr 2021;67:fmab037. [PMID: 34080011 DOI: 10.1093/tropej/fmab037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Leo ZH, Mohammad Iskandar FF, Yeap TB, Bong CP. Perioperative challenges in a morbidly obese former COVID-19 patient undergoing elective spine surgery. BMJ Case Rep 2021;14:e243950. [PMID: 34312139 DOI: 10.1136/bcr-2021-243950] [Reference Citation Analysis]
33 Van Zeebroeck L, Arroyo Hornero R, Côrte-Real BF, Hamad I, Meissner TB, Kleinewietfeld M. Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells. Front Immunol 2021;12:655122. [PMID: 34408743 DOI: 10.3389/fimmu.2021.655122] [Reference Citation Analysis]
34 Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, Rizzo S, De Gaspari M, Basso C, Calabrese F, Dei Tos AP, Fassan M. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci 2021;22:974. [PMID: 33478107 DOI: 10.3390/ijms22020974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Jagtap D, Bhor VM, Bhowmick S, Kasarpalkar N, Sagvekar P, Kulkarni B, Pathak M, Chatterjee N, Dolas P, Palav H, Kaginkar S, Bhagat S, Munshi I, Parikh S, Agrawal S, Pawar C, Kaneria M, Mahale SD, Shastri J, Patel V. sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection. Front Immunol 2021;12:619906. [PMID: 34194420 DOI: 10.3389/fimmu.2021.619906] [Reference Citation Analysis]
36 Feinberg ME, A Mogle J, Lee JK, Tornello SL, Hostetler ML, Cifelli JA, Bai S, Hotez E. Impact of the COVID-19 Pandemic on Parent, Child, and Family Functioning. Fam Process 2021. [PMID: 33830510 DOI: 10.1111/famp.12649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
37 Tokatli MR, Sisti LG, Marziali E, Nachira L, Rossi MF, Amantea C, Moscato U, Malorni W. Hormones and Sex-Specific Medicine in Human Physiopathology. Biomolecules 2022;12:413. [DOI: 10.3390/biom12030413] [Reference Citation Analysis]
38 Hung YP, Lee CC, Lee JC, Tsai PJ, Ko WC. Gut Dysbiosis during COVID-19 and Potential Effect of Probiotics. Microorganisms 2021;9:1605. [PMID: 34442684 DOI: 10.3390/microorganisms9081605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Ren AL, Digby RJ, Needham EJ. Neurological update: COVID-19. J Neurol 2021. [PMID: 33929617 DOI: 10.1007/s00415-021-10581-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
40 Brogna B, Bignardi E, Brogna C, Volpe M, Lombardi G, Rosa A, Gagliardi G, Capasso PFM, Gravino E, Maio F, Pane F, Picariello V, Buono M, Colucci L, Musto LA. A Pictorial Review of the Role of Imaging in the Detection, Management, Histopathological Correlations, and Complications of COVID-19 Pneumonia. Diagnostics (Basel) 2021;11:437. [PMID: 33806423 DOI: 10.3390/diagnostics11030437] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
41 Cai Y, Kim DJ, Takahashi T, Broadhurst DI, Ma S, Rattray NJW, Casanovas-Massana A, Israelow B, Klein J, Lucas C, Mao T, Moore AJ, Muenker MC, Oh J, Silva J, Wong P, Ko AI, Khan SA, Iwasaki A, Johnson CH; Yale IMPACT Research team. Kynurenic acid underlies sex-specific immune responses to COVID-19. medRxiv 2020:2020. [PMID: 32935119 DOI: 10.1101/2020.09.06.20189159] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
42 Liu W, Guan WJ, Zhong NS. Strategies and Advances in Combating COVID-19 in China. Engineering (Beijing) 2020;6:1076-84. [PMID: 33078078 DOI: 10.1016/j.eng.2020.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
43 Rangchaikul P, Venketaraman V. SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations. Infect Dis Rep 2021;13:993-1008. [PMID: 34940401 DOI: 10.3390/idr13040091] [Reference Citation Analysis]
44 Pillalamarri N, Abdullah, Ren G, Khan L, Ullah A, Jonnakuti S, Ullah M. Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage. Transl Oncol. 2021;14:101095. [PMID: 33887552 DOI: 10.1016/j.tranon.2021.101095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Abdoli A, Falahi S, Kenarkoohi A. COVID-19-associated opportunistic infections: a snapshot on the current reports. Clin Exp Med 2021. [PMID: 34424451 DOI: 10.1007/s10238-021-00751-7] [Reference Citation Analysis]
46 Ruggeri RM, Campennì A, Deandreis D, Siracusa M, Tozzoli R, Petranović Ovčariček P, Giovanella L. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol 2021;17:737-59. [PMID: 34015983 DOI: 10.1080/1744666X.2021.1932467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Hazrati E, Gholami M, Farahani RH, Ghorban K, Ghayomzadeh M, Rouzbahani NH. The effect of IGF-1 plasma concentration on COVID-19 severity. Microb Pathog 2022;:105416. [PMID: 35092836 DOI: 10.1016/j.micpath.2022.105416] [Reference Citation Analysis]
48 Mertz P, Jeannel J, Guffroy A, Lescuyer S, Korganow AS, Rondeau-Lutz M, Weber JC. Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases? Autoimmun Rev 2021;20:102824. [PMID: 33864942 DOI: 10.1016/j.autrev.2021.102824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Maitz T, Parfianowicz D, Vojtek A, Rajeswaran Y, Vyas AV, Gupta R. COVID-19 Cardiovascular Connection: A Review of Cardiac Manifestations in COVID-19 Infection and Treatment Modalities. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101186] [Reference Citation Analysis]
50 Lee W, Ahn JH, Park HH, Kim HN, Kim H, Yoo Y, Shin H, Hong KS, Jang JG, Park CG, Choi EY, Bae JS, Seo YK. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduct Target Ther 2020;5:186. [PMID: 32883951 DOI: 10.1038/s41392-020-00292-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
51 Tuan WJ, Spotts H, Zgierska AE, Lennon RP. COVID-19 outcomes among adult patients treated with long-term opioid therapy for chronic non-cancer pain in the USA: a retrospective cohort study. BMJ Open 2021;11:e056436. [PMID: 34836910 DOI: 10.1136/bmjopen-2021-056436] [Reference Citation Analysis]
52 Lami F, Elfadul M, Rashak HA, Al Nsour M, Akhtar H, Khader YS, Hussein AM, Naciri M, Samy S, Ghaleb Y, Taha HA, Aljanabe AH, Ali NA, Zayer RH, Ikram A, Rahman FU, Khan MM, Adam R, Ahmed AY, Afifi S. Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: A Multicountry Retrospective Study . JMIR Public Health Surveill 2021. [PMID: 34736222 DOI: 10.2196/32831] [Reference Citation Analysis]
53 Sadeghsoltani F, Mohammadzadeh I, Safari MM, Hassanpour P, Izadpanah M, Qujeq D, Moein S, Vaghari-Tabari M. Zinc and Respiratory Viral Infections: Important Trace Element in Anti-viral Response and Immune Regulation. Biol Trace Elem Res 2021. [PMID: 34368933 DOI: 10.1007/s12011-021-02859-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev 2021;20:102792. [PMID: 33610751 DOI: 10.1016/j.autrev.2021.102792] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 26.0] [Reference Citation Analysis]
55 Mariajoseph-Antony LF, Kannan A, Panneerselvam A, Loganathan C, Anbarasu K, Prahalathan C. Could aquaporin modulators be employed as prospective drugs for COVID-19 related pulmonary comorbidity? Med Hypotheses 2020;143:110201. [PMID: 33017909 DOI: 10.1016/j.mehy.2020.110201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Chakravarty K, Antontsev VG, Khotimchenko M, Gupta N, Jagarapu A, Bundey Y, Hou H, Maharao N, Varshney J. Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform. Molecules 2021;26:1912. [PMID: 33805419 DOI: 10.3390/molecules26071912] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
57 Cutolo M, Paolino S, Smith V. Evidences for a protective role of vitamin D in COVID-19. RMD Open 2020;6:e001454. [PMID: 33372031 DOI: 10.1136/rmdopen-2020-001454] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
58 Satarker S, Tom AA, Shaji RA, Alosious A, Luvis M, Nampoothiri M. JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy. Postgrad Med 2021;133:489-507. [PMID: 33245005 DOI: 10.1080/00325481.2020.1855921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
59 Hosseini A, Hashemi V, Shomali N, Asghari F, Gharibi T, Akbari M, Gholizadeh S, Jafari A. Innate and adaptive immune responses against coronavirus. Biomed Pharmacother 2020;132:110859. [PMID: 33120236 DOI: 10.1016/j.biopha.2020.110859] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
60 Benazzo M, Cassaniti I, Maiorano E, Calastri A, Novazzi F, Bonetti A, Sarasini A, Bruno R, Baldanti F. SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders. Microorganisms 2020;8:E1052. [PMID: 32679910 DOI: 10.3390/microorganisms8071052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Naidoo D, Kar P, Roy A, Mutanda T, Bwapwa J, Sen A, Anandraj A. Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, Mpro and PLpro of SARS-CoV-2: Protein-Protein Interactions, Dynamics Simulations and Free Energy Calculations. Molecules 2021;26:5114. [PMID: 34500548 DOI: 10.3390/molecules26175114] [Reference Citation Analysis]
62 Hilligan KL, Namasivayam S, Clancy CS, O'Mard D, Oland SD, Robertson SJ, Baker PJ, Castro E, Garza NL, Lafont BAP, Johnson R, Ronchese F, Mayer-Barber KD, Best SM, Sher A. Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge. J Exp Med 2022;219:e20211862. [PMID: 34889942 DOI: 10.1084/jem.20211862] [Reference Citation Analysis]
63 Peirouvi T, Aliaghaei A, Eslami Farsani B, Ziaeipour S, Ebrahimi V, Forozesh M, Ghadipasha M, Mahmoudiasl GR, Aryan A, Moghimi N, Abdi S, Raoofi A, Kargar Godaneh M, Abdollahifar MA. COVID-19 disrupts the blood-testis barrier through the induction of inflammatory cytokines and disruption of junctional proteins. Inflamm Res 2021;70:1165-75. [PMID: 34436630 DOI: 10.1007/s00011-021-01497-4] [Reference Citation Analysis]
64 Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020;21:224. [PMID: 32854739 DOI: 10.1186/s12931-020-01479-w] [Cited by in Crossref: 172] [Cited by in F6Publishing: 1] [Article Influence: 86.0] [Reference Citation Analysis]
65 Niazi Tabar A, Sojoudi K, Henduei H, Azizi H. Review of Sertoli cell dysfunction caused by COVID-19 that could affect male fertility. Zygote 2021;:1-8. [PMID: 34176527 DOI: 10.1017/S0967199421000320] [Reference Citation Analysis]
66 Shi C, Tingting W, Li JP, Sullivan MA, Wang C, Wang H, Deng B, Zhang Y. Comprehensive Landscape of Heparin Therapy for COVID-19. Carbohydr Polym 2021;254:117232. [PMID: 33357843 DOI: 10.1016/j.carbpol.2020.117232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
67 Haslbauer JD, Tzankov A, Mertz KD, Schwab N, Nienhold R, Twerenbold R, Leibundgut G, Stalder AK, Matter M, Glatz K. Characterisation of cardiac pathology in 23 autopsies of lethal COVID-19. J Pathol Clin Res 2021;7:326-37. [PMID: 33837673 DOI: 10.1002/cjp2.212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
68 Manzo C, Castagna A, Ruotolo G. Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica? Joint Bone Spine 2021;88:105150. [PMID: 33588357 DOI: 10.1016/j.jbspin.2021.105150] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Daoust L, Pilon G, Marette A. Perspective: Nutritional Strategies Targeting the Gut Microbiome to Mitigate COVID-19 Outcomes. Adv Nutr 2021;12:1074-86. [PMID: 33783468 DOI: 10.1093/advances/nmab031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
70 Aslan A, Aslan C, Zolbanin NM, Jafari R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia (Nathan) 2021;13:14. [PMID: 34872623 DOI: 10.1186/s41479-021-00092-9] [Reference Citation Analysis]
71 Kapoor N, Ghorai SM, Kushwaha PK, Shukla R, Aggarwal C, Bandichhor R. Plausible mechanisms explaining the role of cucurbitacins as potential therapeutic drugs against coronavirus 2019. Inform Med Unlocked 2020;21:100484. [PMID: 33251326 DOI: 10.1016/j.imu.2020.100484] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
72 Gierlikowska B, Stachura A, Gierlikowski W, Demkow U. Phagocytosis, Degranulation and Extracellular Traps Release by Neutrophils-The Current Knowledge, Pharmacological Modulation and Future Prospects. Front Pharmacol 2021;12:666732. [PMID: 34017259 DOI: 10.3389/fphar.2021.666732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Mamdouh Elsayed M, Zeid MM, Fayed AM, Elreweny EM, Zakaria NH, Baess AI. Does therapeutic plasma exchange have a role in resistant cytokine storm state of COVID-19 infection? Alexandria Journal of Medicine 2021;57:235-9. [DOI: 10.1080/20905068.2021.1987111] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 van Eeden C, Khan L, Osman MS, Cohen Tervaert JW. Natural Killer Cell Dysfunction and Its Role in COVID-19. Int J Mol Sci 2020;21:E6351. [PMID: 32883007 DOI: 10.3390/ijms21176351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
75 Page EM, Ariëns RAS. Mechanisms of thrombosis and cardiovascular complications in COVID-19. Thromb Res 2021;200:1-8. [PMID: 33493983 DOI: 10.1016/j.thromres.2021.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
76 Nazerian Y, Vakili K, Ebrahimi A, Niknejad H. Developing Cytokine Storm-Sensitive Therapeutic Strategy in COVID-19 Using 8P9R Chimeric Peptide and Soluble ACE2. Front Cell Dev Biol 2021;9:717587. [PMID: 34540833 DOI: 10.3389/fcell.2021.717587] [Reference Citation Analysis]
77 Kumar S, Shanker OR, Kumari N, Tripathi M, Chandra PS, Dixit AB, Banerjee J. Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets. Expert Opin Ther Targets 2021;25:509-19. [PMID: 34232801 DOI: 10.1080/14728222.2021.1953475] [Reference Citation Analysis]
78 Españo E, Kim D, Kim J, Park SK, Kim JK. COVID-19 Antiviral and Treatment Candidates: Current Status. Immune Netw 2021;21:e7. [PMID: 33728100 DOI: 10.4110/in.2021.21.e7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Kumar V. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int Immunopharmacol 2020;89:107087. [PMID: 33075714 DOI: 10.1016/j.intimp.2020.107087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
80 Dhillon A, Deme JC, Furlong E, Roem D, Jongerius I, Johnson S, Lea SM. Molecular Basis for Bordetella pertussis Interference with Complement, Coagulation, Fibrinolytic, and Contact Activation Systems: the Cryo-EM Structure of the Vag8-C1 Inhibitor Complex. mBio 2021;12:e02823-20. [PMID: 33758081 DOI: 10.1128/mBio.02823-20] [Reference Citation Analysis]
81 Stack M, Sacco K, Castagnoli R, Livinski AA, Notarangelo LD, Lionakis MS. BTK inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A systematic review. Clin Immunol 2021;230:108816. [PMID: 34352390 DOI: 10.1016/j.clim.2021.108816] [Reference Citation Analysis]
82 Bezemer GFG, Garssen J. TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target. Front Pharmacol 2020;11:601685. [PMID: 33519463 DOI: 10.3389/fphar.2020.601685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
83 Hilligan KL, Namasivayam S, Clancy CS, O'Mard D, Oland SD, Robertson SJ, Baker PJ, Castro E, Garza NL, Lafont BAP, Johnson R, Ronchese F, Mayer-Barber KD, Best SM, Sher A. Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge. bioRxiv 2021:2021. [PMID: 34494021 DOI: 10.1101/2021.08.30.458273] [Reference Citation Analysis]
84 Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun 2020;3:100073. [PMID: 33263103 DOI: 10.1016/j.jtauto.2020.100073] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
85 Chen C, Lin S, Shen C, Hsieh K, Cheng C. Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes. Diagnostics 2022;12:509. [DOI: 10.3390/diagnostics12020509] [Reference Citation Analysis]
86 Waterer GW. Applying the lessons learned from coronavirus disease 2019 to improve pneumonia management. Curr Opin Infect Dis 2021;34:175-9. [PMID: 33492003 DOI: 10.1097/QCO.0000000000000710] [Reference Citation Analysis]
87 Nieto-Fontarigo JJ, Tillgren S, Cerps S, Sverrild A, Hvidtfeldt M, Ramu S, Menzel M, Sander AF, Porsbjerg C, Uller L. Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma. Front Immunol 2021;12:743890. [PMID: 34950134 DOI: 10.3389/fimmu.2021.743890] [Reference Citation Analysis]
88 Al Kassaa I, El Omari S, Abbas N, Papon N, Drider D, Kassem II, Osman M. High association of COVID-19 severity with poor gut health score in Lebanese patients. PLoS One 2021;16:e0258913. [PMID: 34673813 DOI: 10.1371/journal.pone.0258913] [Reference Citation Analysis]
89 Amaral JL, Oliveira JTA, Lopes FES, Freitas CDT, Freire VN, Abreu LV, Souza PFN. Quantum biochemistry, molecular docking, and dynamics simulation revealed synthetic peptides induced conformational changes affecting the topology of the catalytic site of SARS-CoV-2 main protease. J Biomol Struct Dyn 2021;:1-13. [PMID: 33949286 DOI: 10.1080/07391102.2021.1920464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Laha S, Saha C, Dutta S, Basu M, Chatterjee R, Ghosh S, Bhattacharyya NP. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors. Heliyon 2021;7:e06395. [PMID: 33688586 DOI: 10.1016/j.heliyon.2021.e06395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
91 Pigliacelli F, Pacifico A, Mariano M, D'Arino A, Cristaudo A, Iacovelli P. Morphea induced by SARS-CoV-2 infection: A case report. Int J Dermatol 2021. [PMID: 34783020 DOI: 10.1111/ijd.15983] [Reference Citation Analysis]
92 Deng K, Fan Q, Yang Y, Deng X, He R, Tan Y, Lan Y, Deng X, Pan Y, Wang Y, Guan Y, Liu H, Chen F, Mo X, Tan X, Luo C, Wen X, Liu Y, Liu J, Zhang L, Tang X, Hu F, Li F. Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: A longitudinal retrospective analysis. J Med Virol 2021;93:2505-12. [PMID: 33433006 DOI: 10.1002/jmv.26793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
93 Mosalli R, Al Matrafi A, Ghazi MA, Aboumousatafa GA, Paes B. COVID-19 Infection in Spinal Muscular Atrophy Associated with Multisystem Inflammatory Syndrome. Case Rep Pediatr 2021;2021:5862444. [PMID: 34306789 DOI: 10.1155/2021/5862444] [Reference Citation Analysis]
94 Manganotti P, Bellavita G, Tommasini V, D Acunto L, Fabris M, Cecotti L, Furlanis G, Sartori A, Bonzi L, Buoite Stella A, Pesavento V. Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients. J Med Virol 2021;93:5432-7. [PMID: 33951196 DOI: 10.1002/jmv.27061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
95 da Silva KN, Gobatto ALN, Costa-Ferro ZSM, Cavalcante BRR, Caria ACI, de Aragão França LS, Nonaka CKV, de Macêdo Lima F, Lopes-Pacheco M, Rocco PRM, de Freitas Souza BS. Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19? Stem Cell Res Ther 2021;12:425. [PMID: 34315546 DOI: 10.1186/s13287-021-02502-7] [Reference Citation Analysis]
96 Bergamaschi L, D'Angelo EC, Paolisso P, Toniolo S, Fabrizio M, Angeli F, Donati F, Magnani I, Rinaldi A, Bartoli L, Chiti C, Biffi M, Pizzi C, Viale P, Galié N. The value of ECG changes in risk stratification of COVID-19 patients. Ann Noninvasive Electrocardiol 2021;26:e12815. [PMID: 33512742 DOI: 10.1111/anec.12815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Kumar A, Kumar A, Kumar A, Kumar N, Sinha C, Singh V. Multiple Peaked Cytokine Storm: Is Multiple Exposures to the COVID-19 Virus a Possible Cause? Indian J Crit Care Med 2021;25:463-4. [PMID: 34045815 DOI: 10.5005/jp-journals-10071-23786] [Reference Citation Analysis]
98 Liu X, Mostafavi H, Ng WH, Freitas JR, King NJC, Zaid A, Taylor A, Mahalingam S. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan. mBio 2022;:e0068322. [PMID: 35420469 DOI: 10.1128/mbio.00683-22] [Reference Citation Analysis]
99 Santos GSP, Costa AC, Picoli CC, Rocha BGS, Sulaiman SO, Radicchi DC, Pinto MCX, Batista ML Jr, Amorim JH, Azevedo VAC, Resende RR, Câmara NOS, Mintz A, Birbrair A. Sympathetic nerve-adipocyte interactions in response to acute stress. J Mol Med (Berl) 2021. [PMID: 34735579 DOI: 10.1007/s00109-021-02157-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Cao L, Mu W. Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications. Pharmacol Res 2021;163:105297. [PMID: 33181319 DOI: 10.1016/j.phrs.2020.105297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
101 Demiri J, Abdo M, Tsianakas A. [Erythrodermic psoriasis after COVID-19]. Hautarzt 2021. [PMID: 34905074 DOI: 10.1007/s00105-021-04931-0] [Reference Citation Analysis]
102 Sur S, Khatun M, Steele R, Isbell TS, Ray R, Ray RB. Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-β in Triggering Inflammatory Signals in Cells of Distant Organ. Int J Mol Sci 2021;22:3184. [PMID: 33804769 DOI: 10.3390/ijms22063184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
103 Kitchen LC, Berman M, Halper J, Chazot P. Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70. IJMS 2022;23:5221. [DOI: 10.3390/ijms23095221] [Reference Citation Analysis]
104 Huntington KE, Louie AD, Lee CG, Elias JA, Ross EA, El-Deiry WS. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients with COVID-19. medRxiv 2020:2020. [PMID: 33269361 DOI: 10.1101/2020.11.24.20235721] [Reference Citation Analysis]
105 Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genomics 2020;52:549-57. [PMID: 32991251 DOI: 10.1152/physiolgenomics.00089.2020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
106 Ghazanfar H, Kandhi S, Shin D, Muthumanickam A, Gurjar H, Qureshi ZA, Shaban M, Farag M, Haider A, Budhathoki P, Bhatt T, Ghazanfar A, Jyala A, Patel H. Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review. Cureus. [DOI: 10.7759/cureus.23333] [Reference Citation Analysis]
107 Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors 2021;47:232-41. [PMID: 33847020 DOI: 10.1002/biof.1726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
108 Shrivastava R, Shrivastava R, Johansen B, Allain T. Anti-Inflammatory and Antiviral Osmotic Polymeric Film to Treat Covid-19 Early-Stage Infection. J Inflamm Res 2021;14:1195-206. [PMID: 33833542 DOI: 10.2147/JIR.S306434] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Shakeeb N, Varkey P, Hynse A, Mandlecha A. Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR. Inflammopharmacology 2022. [PMID: 35320494 DOI: 10.1007/s10787-022-00951-x] [Reference Citation Analysis]
110 Noh S, Lee H, Kim J, Jang H, An J, Park C, Lee M, Lee T. Rapid electrochemical dual-target biosensor composed of an Aptamer/MXene hybrid on Au microgap electrodes for cytokines detection. Biosensors and Bioelectronics 2022;207:114159. [DOI: 10.1016/j.bios.2022.114159] [Reference Citation Analysis]
111 Turkin A, Tuchina O, Klempin F. Microglia Function on Precursor Cells in the Adult Hippocampus and Their Responsiveness to Serotonin Signaling. Front Cell Dev Biol 2021;9:665739. [PMID: 34109176 DOI: 10.3389/fcell.2021.665739] [Reference Citation Analysis]
112 Regele F, Oberbauer R. [COVID-19 and renal transplantation]. Nephrologe 2021;:1-8. [PMID: 33532003 DOI: 10.1007/s11560-021-00485-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Shawki MA, Elsayed NS, Mantawy EM, Said RS. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications. Immunopharmacol Immunotoxicol 2021;43:395-409. [PMID: 34057871 DOI: 10.1080/08923973.2021.1931302] [Reference Citation Analysis]
114 Salahshoori I, Mobaraki-asl N, Seyfaee A, Mirzaei Nasirabad N, Dehghan Z, Faraji M, Ganjkhani M, Babapoor A, Shadmehr SZ, Hamrang A. Overview of COVID-19 Disease: Virology, Epidemiology, Prevention Diagnosis, Treatment, and Vaccines. Biologics 2021;1:2-40. [DOI: 10.3390/biologics1010002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
115 Li H, Liu R, Zhang R, Zhang S, Wei Y, Zhang L, Zhou H, Yang C. Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice. Front Pharmacol 2020;11:607075. [PMID: 33584285 DOI: 10.3389/fphar.2020.607075] [Reference Citation Analysis]
116 Hafezi B, Chan L, Knapp JP, Karimi N, Alizadeh K, Mehrani Y, Bridle BW, Karimi K. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells. Cells 2021;10:1761. [PMID: 34359931 DOI: 10.3390/cells10071761] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Karmouty-Quintana H, Thandavarayan RA, Keller SP, Sahay S, Pandit LM, Akkanti B. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets. Int J Mol Sci 2020;21:E8081. [PMID: 33138181 DOI: 10.3390/ijms21218081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
118 Stack M, Sacco K, Castagnoli R, Livinski AA, Notarangelo LD, Lionakis MS. BTK inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review. Res Sq 2021:rs. [PMID: 33791689 DOI: 10.21203/rs.3.rs-319342/v1] [Reference Citation Analysis]
119 Bwire G, Ario AR, Eyu P, Ocom F, Wamala JF, Kusi KA, Ndeketa L, Jambo KC, Wanyenze RK, Talisuna AO. The COVID-19 pandemic in the African continent. BMC Med 2022;20:167. [PMID: 35501853 DOI: 10.1186/s12916-022-02367-4] [Reference Citation Analysis]
120 Hailemichael W, Kiros M, Akelew Y, Getu S, Andualem H. Neopterin: A Promising Candidate Biomarker for Severe COVID-19. J Inflamm Res 2021;14:245-51. [PMID: 33564258 DOI: 10.2147/JIR.S290264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
121 Li W, Rios S, Nagraj S, Hajra A, Saralidze T, Varrias D, Mathai SV, Novakovic M, Hupart KH, Miles JA, Katamreddy A, Palaiodimos L, Faillace RT. Statin use in hospitalized patients with COVID-19: A comprehensive analysis of the New York City Public Hospital System. Am J Med 2022:S0002-9343(22)00169-3. [PMID: 35296403 DOI: 10.1016/j.amjmed.2022.02.018] [Reference Citation Analysis]
122 Numbers K, Brodaty H. The effects of the COVID-19 pandemic on people with dementia. Nat Rev Neurol 2021;17:69-70. [PMID: 33408384 DOI: 10.1038/s41582-020-00450-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
123 Hegyi PJ, Váncsa S, Ocskay K, Dembrovszky F, Kiss S, Farkas N, Erőss B, Szakács Z, Hegyi P, Pár G. Metabolic Associated Fatty Liver Disease Is Associated With an Increased Risk of Severe COVID-19: A Systematic Review With Meta-Analysis. Front Med (Lausanne) 2021;8:626425. [PMID: 33777974 DOI: 10.3389/fmed.2021.626425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
124 Lakota K, Perdan-Pirkmajer K, Hočevar A, Sodin-Semrl S, Rotar Ž, Čučnik S, Žigon P. COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases. Front Immunol 2020;11:611318. [PMID: 33574819 DOI: 10.3389/fimmu.2020.611318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
125 Halaji M, Heiat M, Faraji N, Ranjbar R. Epidemiology of COVID-19: An updated review. J Res Med Sci 2021;26:82. [PMID: 34759999 DOI: 10.4103/jrms.JRMS_506_20] [Reference Citation Analysis]
126 Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 2020;21:224. [PMID: 32854739 DOI: 10.1186/s12931-020-01479-w] [Cited by in Crossref: 112] [Cited by in F6Publishing: 82] [Article Influence: 56.0] [Reference Citation Analysis]
127 Callaghan PJ, Rybakovsky E, Ferrick B, Thomas S, Mullin JM. Retinoic acid improves baseline barrier function and attenuates TNF-α-induced barrier leak in human bronchial epithelial cell culture model, 16HBE 14o. PLoS One 2020;15:e0242536. [PMID: 33301441 DOI: 10.1371/journal.pone.0242536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Kerget F, Kerget B, İba Yılmaz S, Kızıltunç A. Evaluation of the relationship between TREM-1/TREM-2 ratio and clinical course in COVID-19 pneumonia. Int J Clin Pract 2021;:e14697. [PMID: 34365706 DOI: 10.1111/ijcp.14697] [Reference Citation Analysis]
129 Chuang TY, Tsai MH, Wu LM, Ho SJ, Yeh PS, Liu YL, Fred Yang HJ. Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19. J Microbiol Immunol Infect 2020:S1684-1182(20)30241-3. [PMID: 34756359 DOI: 10.1016/j.jmii.2020.09.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Nekrasova LA, Jain M, Gubenko NS, Budko AA, Samokhodskaya LM, Orlova IA, Kamalov AA. Possibility of blood test parameters usage in the evaluation of COVID-19 patients’ inflammatory status. Journal of Clinical Practice 2022;13:14-21. [DOI: 10.17816/clinpract80111] [Reference Citation Analysis]
131 Kifle ZD, Woldeyohanis AE, Demeke CA. A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19. Metabol Open 2021;12:100137. [PMID: 34664036 DOI: 10.1016/j.metop.2021.100137] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Shah SB. COVID-19 and Progesterone: Part 1.SARS-CoV-2, Progesterone and its potential clinical use. Endocr Metab Sci 2021;:100109. [PMID: 34396353 DOI: 10.1016/j.endmts.2021.100109] [Reference Citation Analysis]
133 Durdagi S, Dağ Ç, Dogan B, Yigin M, Avsar T, Buyukdag C, Erol I, Ertem FB, Calis S, Yildirim G, Orhan MD, Guven O, Aksoydan B, Destan E, Sahin K, Besler SO, Oktay L, Shafiei A, Tolu I, Ayan E, Yuksel B, Peksen AB, Gocenler O, Yucel AD, Can O, Ozabrahamyan S, Olkan A, Erdemoglu E, Aksit F, Tanisali G, Yefanov OM, Barty A, Tolstikova A, Ketawala GK, Botha S, Dao EH, Hayes B, Liang M, Seaberg MH, Hunter MS, Batyuk A, Mariani V, Su Z, Poitevin F, Yoon CH, Kupitz C, Sierra RG, Snell EH, DeMirci H. Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing. Structure 2021:S0969-2126(21)00257-4. [PMID: 34403647 DOI: 10.1016/j.str.2021.07.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
134 Chatzikonstantinou T, Herishanu Y, Montserrat E, Ghia P, Cuneo A, Foà R, Scarfò L. COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand Now. Cancer J 2021;27:328-33. [PMID: 34398560 DOI: 10.1097/PPO.0000000000000535] [Reference Citation Analysis]
135 Moretto F, Sixt T, Devilliers H, Abdallahoui M, Eberl I, Rogier T, Buisson M, Chavanet P, Duong M, Esteve C, Mahy S, Salmon-Rousseau A, Catherine F, Blot M, Piroth L. Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19? Int J Infect Dis 2021;105:256-60. [PMID: 33508478 DOI: 10.1016/j.ijid.2021.01.051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
136 Yusuf AP, Zhang J, Li J, Muhammad A, Abubakar MB. Herbal medications and natural products for patients with covid-19 and diabetes mellitus: potentials and challenges. Phytomedicine Plus 2022. [DOI: 10.1016/j.phyplu.2022.100280] [Reference Citation Analysis]
137 Battina HL, Alentado VJ, Srour EF, Moliterno AR, Kacena MA. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection. Exp Hematol 2021:S0301-472X(21)00328-3. [PMID: 34563606 DOI: 10.1016/j.exphem.2021.09.005] [Reference Citation Analysis]
138 Jadali Z. COVID- 19 AND THYROID INFECTION: LEARNING THE LESSONS OF THE PAST. Acta Endocrinol (Buchar) 2020;16:375-6. [PMID: 33363664 DOI: 10.4183/aeb.2020.375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
139 Ai J, Hong W, Wu M, Wei X. Pulmonary vascular system: A vulnerable target for COVID-19. MedComm (2020) 2021. [PMID: 34909758 DOI: 10.1002/mco2.94] [Reference Citation Analysis]
140 Akhmedov VA. Correction of intestinal microbial composition disturbances as a potential link in complex therapy of patients with COVID-19. Terapevticheskii arkhiv 2022;94:277-82. [DOI: 10.26442/00403660.2022.02.201388] [Reference Citation Analysis]
141 Murlanova K, Begmatova D, Weber-Stadlbauer U, Meyer U, Pletnikov M, Pinhasov A. Double trouble: Prenatal immune activation in stress sensitive offspring. Brain Behav Immun 2021;99:3-8. [PMID: 34547401 DOI: 10.1016/j.bbi.2021.09.004] [Reference Citation Analysis]
142 Tripathi K, Godoy Brewer G, Thu Nguyen M, Singh Y, Saleh Ismail M, Sauk JS, Parian AM, Limketkai BN. COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. Inflamm Bowel Dis 2021:izab236. [PMID: 34718595 DOI: 10.1093/ibd/izab236] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Khandait H, Gandotra G, Sachdeva S, Kramer CA, Nye D, Golamari R, Jain R. COVID-19 and Hematology-What Do We Know So Far? SN Compr Clin Med 2020;:1-6. [PMID: 33134847 DOI: 10.1007/s42399-020-00607-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
144 Kerget F, Kerget B, Kahraman ÇY, Araz Ö, Akgün M, Uçar EY, Sağlam L. Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19. J Med Virol 2021. [PMID: 34314051 DOI: 10.1002/jmv.27238] [Reference Citation Analysis]
145 Chatterjee S, Mishra S, Chowdhury KD, Ghosh CK, Saha KD. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view. Life Sci 2021;278:119580. [PMID: 33991549 DOI: 10.1016/j.lfs.2021.119580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Samara A, Herlenius E. Is There an Effect of Fetal Mesenchymal Stem Cells in the Mother-Fetus Dyad in COVID-19 Pregnancies and Vertical Transmission? Front Physiol 2020;11:624625. [PMID: 33679426 DOI: 10.3389/fphys.2020.624625] [Reference Citation Analysis]
147 Vilella A, Trilla A. The COVID-19 Pandemic-an Epidemiological Perspective. Curr Allergy Asthma Rep 2021;21:29. [PMID: 33907920 DOI: 10.1007/s11882-021-01007-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Liu T, Balzano-Nogueira L, Lleo A, Conesa A. Transcriptional Differences for COVID-19 Disease Map Genes between Males and Females Indicate a Different Basal Immunophenotype Relevant to the Disease. Genes (Basel) 2020;11:E1447. [PMID: 33271804 DOI: 10.3390/genes11121447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
149 Lotfi R, Kalmarzi RN, Roghani SA. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2). Immunol Res 2021;69:213-24. [PMID: 33928531 DOI: 10.1007/s12026-021-09198-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Galati D, Zanotta S, Capitelli L, Bocchino M. A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines. Allergy 2021. [PMID: 34245591 DOI: 10.1111/all.15004] [Reference Citation Analysis]
151 Dabbish AM, Yonis N, Salama M, Essa MM, Qoronfleh MW. Inflammatory pathways and potential therapies for COVID-19: A mini review. Eur J Inflamm 2021;19:205873922110029. [DOI: 10.1177/20587392211002986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
152 Kharazmi AB, Moradi O, Haghighi M, Kouchek M, Manafi-Rasi A, Raoufi M, Shoaei SD, Hadavand F, Nabavi M, Miri MM, Salarian S, Shojaei S, Khalili S, Sistanizad M, Sadeghi S, Karagah A, Asgari S, Jaffaraghaei M, Araghi S. A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19. Immun Inflamm Dis 2021. [PMID: 34762351 DOI: 10.1002/iid3.563] [Reference Citation Analysis]
153 Mercan M, Şehirli AÖ, Chukwunyere U, Abacıoğlu N. Acute kidney injury due to COVID-19 and the circadian rhythm. Med Hypotheses 2021;146:110463. [PMID: 33387941 DOI: 10.1016/j.mehy.2020.110463] [Reference Citation Analysis]
154 Cardoso EOC, Fine N, Glogauer M, Johnson F, Goldberg M, Golub LM, Tenenbaum HC. The Advent of COVID-19; Periodontal Research Has Identified Therapeutic Targets for Severe Respiratory Disease; an Example of Parallel Biomedical Research Agendas. Front Dent Med 2021;2:674056. [DOI: 10.3389/fdmed.2021.674056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Zhang Z, Cui F, Cao C, Wang Q, Zou Q. Single-cell RNA analysis reveals the potential risk of organ-specific cell types vulnerable to SARS-CoV-2 infections. Comput Biol Med 2021;140:105092. [PMID: 34864302 DOI: 10.1016/j.compbiomed.2021.105092] [Reference Citation Analysis]
156 Loke XY, Imran SAM, Tye GJ, Wan Kamarul Zaman WS, Nordin F. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID. Int J Mol Sci 2021;22:12421. [PMID: 34830303 DOI: 10.3390/ijms222212421] [Reference Citation Analysis]
157 Garg M, Sharma AL, Singh S. Advancement in biosensors for inflammatory biomarkers of SARS-CoV-2 during 2019-2020. Biosens Bioelectron 2021;171:112703. [PMID: 33049563 DOI: 10.1016/j.bios.2020.112703] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
158 Hopp MT, Domingo-Fernández D, Gadiya Y, Detzel MS, Graf R, Schmalohr BF, Kodamullil AT, Imhof D, Hofmann-Apitius M. Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach. Biomolecules 2021;11:644. [PMID: 33925394 DOI: 10.3390/biom11050644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Hong Y, Truong AD, Vu TH, Lee S, Heo J, Kang S, Lillehoj HS, Hong YH. Exosomes from H5N1 avian influenza virus-infected chickens regulate antiviral immune responses of chicken immune cells. Developmental & Comparative Immunology 2022. [DOI: 10.1016/j.dci.2022.104368] [Reference Citation Analysis]
160 Mangge H, Herrmann M, Meinitzer A, Pailer S, Curcic P, Sloup Z, Holter M, Prüller F. Increased Kynurenine Indicates a Fatal Course of COVID-19. Antioxidants (Basel) 2021;10:1960. [PMID: 34943063 DOI: 10.3390/antiox10121960] [Reference Citation Analysis]
161 Castleman MJ, Stumpf MM, Therrien NR, Smith MJ, Lesteberg KE, Palmer BE, Maloney JP, Janssen WJ, Mould KJ, Beckham JD, Pelanda R, Torres RM. SARS-CoV-2 infection relaxes peripheral B cell tolerance. J Exp Med 2022;219:e20212553. [PMID: 35420627 DOI: 10.1084/jem.20212553] [Reference Citation Analysis]
162 Cai Y, Kim DJ, Takahashi T, Broadhurst DI, Yan H, Ma S, Rattray NJW, Casanovas-Massana A, Israelow B, Klein J, Lucas C, Mao T, Moore AJ, Muenker MC, Oh JE, Silva J, Wong P, Ko AI, Khan SA, Iwasaki A, Johnson CH; Yale IMPACT Research team. Kynurenic acid may underlie sex-specific immune responses to COVID-19. Sci Signal 2021;14:eabf8483. [PMID: 34230210 DOI: 10.1126/scisignal.abf8483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
163 Lee S, Channappanavar R, Kanneganti TD. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.Trends Immunol. 2020;41:1083-1099. [PMID: 33153908 DOI: 10.1016/j.it.2020.10.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 47] [Article Influence: 19.5] [Reference Citation Analysis]
164 Fisk M, Althage M, Moosmang S, Greasley PJ, Cope AP, Jayne DR, Galloway J, Hall F, Wilkinson IB, Ambery P, Cheriyan J. Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19. Pulm Pharmacol Ther 2021;69:102035. [PMID: 33933611 DOI: 10.1016/j.pupt.2021.102035] [Reference Citation Analysis]
165 Cavalli G, Farina N, Campochiaro C, De Luca G, Della-Torre E, Tomelleri A, Dagna L. Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic. Front Pharmacol 2020;11:598308. [PMID: 33442386 DOI: 10.3389/fphar.2020.598308] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
166 Amri MM, Drummond D. Punctuating the equilibrium: an application of policy theory to COVID-19. Policy Design and Practice. [DOI: 10.1080/25741292.2020.1841397] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
167 Ghashghaeinia M, Dreischer P, Wieder T, Köberle M. Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication. Cell Cycle 2020;19:3399-405. [PMID: 33305655 DOI: 10.1080/15384101.2020.1859197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
168 Frankel AE, Yip WC, Naik E, Hasselbalch HC. Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus. Clin Case Rep 2021;9:e04218. [PMID: 34136234 DOI: 10.1002/ccr3.4218] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Vázquez-Medina MU, Cerda-Reyes E, Galeana-Pavón A, López-Luna CE, Ramírez-Portillo PM, Ibañez-Cervantes G, Torres-Vázquez J, Vargas-De-León C. Interaction of metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019. Hepatol Commun 2022. [PMID: 35438253 DOI: 10.1002/hep4.1957] [Reference Citation Analysis]
170 Murdaca G, Paladin F, Tonacci A, Isola S, Allegra A, Gangemi S. The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic. Biomedicines 2021;9:1688. [PMID: 34829918 DOI: 10.3390/biomedicines9111688] [Reference Citation Analysis]
171 Gefen A, Ousey K. COVID-19: pressure ulcers, pain and the cytokine storm. J Wound Care 2020;29:540-2. [DOI: 10.12968/jowc.2020.29.10.540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
172 Vaghari-Tabari M, Mohammadzadeh I, Qujeq D, Majidinia M, Alemi F, Younesi S, Mahmoodpoor A, Maleki M, Yousefi B, Asemi Z. Vitamin D in respiratory viral infections: a key immune modulator? Crit Rev Food Sci Nutr 2021;:1-16. [PMID: 34470511 DOI: 10.1080/10408398.2021.1972407] [Reference Citation Analysis]
173 Barros CMSS, Freire RS, Frota E, Rezende Santos AG, Farias MEL, Rodrigues MGA, Silva BM, Prado Jeronimo CM, Netto RLA, Silva Borba MG, Baía-da-Silva D, Brito-Sousa JD, Xavier MS, Araújo-Alexandre MA, Sampaio VS, Melo GC, Arêas GT, Hajjar LA, Monteiro WM, Gomes Naveca F, Costa FTM, Val FFA, Lacerda MVG; Metcovid team. Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial. Front Med (Lausanne) 2021;8:758405. [PMID: 34917633 DOI: 10.3389/fmed.2021.758405] [Reference Citation Analysis]
174 Primorac D, Čemerin M, Matišić V, Molnar V, Strbad M, Girandon L, Zenić L, Knežević M, Minger S, Polančec D. Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment. Pharmaceutics 2021;13:1481. [PMID: 34575557 DOI: 10.3390/pharmaceutics13091481] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Brien ME, Bouron-Dal Soglio D, Dal Soglio S, Couture C, Boucoiran I, Nasr Y, Widdows K, Sharps MC, El Demellawy D, Ep Heazell A, Menzies D, Girard S. Pandemic stress and SARS-CoV-2 infection are associated with pathological changes at the maternal-fetal interface. Placenta 2021;115:37-44. [PMID: 34537470 DOI: 10.1016/j.placenta.2021.09.007] [Reference Citation Analysis]
176 Callahan V, Hawks S, Crawford MA, Lehman CW, Morrison HA, Ivester HM, Akhrymuk I, Boghdeh N, Flor R, Finkielstein CV, Allen IC, Weger-Lucarelli J, Duggal N, Hughes MA, Kehn-Hall K. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner. Viruses 2021;13:1062. [PMID: 34205098 DOI: 10.3390/v13061062] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
177 Argañaraz GA, Palmeira JDF, Argañaraz ER. Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19. Cell Commun Signal 2020;18:190. [PMID: 33357215 DOI: 10.1186/s12964-020-00687-7] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
178 Samuel SM, Varghese E, Büsselberg D. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role. Trends Microbiol 2021:S0966-842X(21)00063-9. [PMID: 33785249 DOI: 10.1016/j.tim.2021.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
179 Bianchi F, Sommariva M, Le Noci V, Camelliti S, Gagliano N, Giussani M, Balsari A, Tagliabue E, Sfondrini L. Aerosol 1,25-dihydroxyvitamin D3 supplementation: A strategy to boost anti-tumor innate immune activity. PLoS One 2021;16:e0248789. [PMID: 33780475 DOI: 10.1371/journal.pone.0248789] [Reference Citation Analysis]
180 Mittal A, Dua A, Gupta S, Injeti E. A research update: Significance of cytokine storm and diaphragm in COVID-19. Curr Res Pharmacol Drug Discov 2021;2:100031. [PMID: 34870147 DOI: 10.1016/j.crphar.2021.100031] [Reference Citation Analysis]
181 Witkowski JM. Immune system aging and the aging-related diseases in the COVIID-19 era. Immunology Letters 2022. [DOI: 10.1016/j.imlet.2022.01.005] [Reference Citation Analysis]
182 Rahimzadeh H, Keykhaei M, Razeghi E, Zivari E, Mansouri ES. COVID-19 progression in kidney transplant recipients: a single-center case series. CEN Case Rep 2021;10:494-9. [PMID: 33770414 DOI: 10.1007/s13730-021-00584-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Giordo R, Paliogiannis P, Mangoni AA, Pintus G. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives. Vasc Biol 2021;3:R15-23. [PMID: 33659858 DOI: 10.1530/VB-20-0017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
184 Akinbolade S, Coughlan D, Fairbairn R, McConkey G, Powell H, Ogunbayo D, Craig D. Combination therapies for COVID-19: An overview of the clinical trials landscape. Br J Clin Pharmacol 2021. [PMID: 34558094 DOI: 10.1111/bcp.15089] [Reference Citation Analysis]
185 Nair R, Soni M, Bajpai B, Dhiman G, Sagayam KM. Predicting the Death Rate Around the World Due to COVID-19 Using Regression Analysis: . International Journal of Swarm Intelligence Research 2022;13:1-13. [DOI: 10.4018/ijsir.287545] [Reference Citation Analysis]
186 Feehan J, de Courten M, Apostolopoulos V, de Courten B. Nutritional Interventions for COVID-19: A Role for Carnosine? Nutrients 2021;13:1463. [PMID: 33925783 DOI: 10.3390/nu13051463] [Reference Citation Analysis]
187 Ling V, Zabetakis I. The Role of an Anti-Inflammatory Diet in Conjunction to COVID-19. Diseases 2021;9:76. [PMID: 34842636 DOI: 10.3390/diseases9040076] [Reference Citation Analysis]
188 Hussain MS, Sharma P, Dhanjal DS, Khurana N, Vyas M, Sharma N, Mehta M, Tambuwala MM, Satija S, Sohal SS, Oliver BGG, Sharma HS. Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases. Chem Biol Interact 2021;348:109637. [PMID: 34506765 DOI: 10.1016/j.cbi.2021.109637] [Reference Citation Analysis]
189 Lamadrid P, Alonso-Peña M, San Segundo D, Arias-Loste M, Crespo J, Lopez-Hoyos M. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity. Front Immunol 2021;12:651728. [PMID: 33859644 DOI: 10.3389/fimmu.2021.651728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
190 Abusalah MAH, Khalifa M, Al-hatamleh MAI, Jarrar M, Mohamud R, Chan YY. Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm. JPM 2022;12:386. [DOI: 10.3390/jpm12030386] [Reference Citation Analysis]
191 Madureira G, Soares R. The misunderstood link between SARS-CoV-2 and angiogenesis. A narrative review. Pulmonology 2021:S2531-0437(21)00160-4. [PMID: 34593362 DOI: 10.1016/j.pulmoe.2021.08.004] [Reference Citation Analysis]
192 Renaud-Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, Rosenblat JD, Lee Y, Subramaniapillai M, McIntyre RS. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res 2021;144:129-37. [PMID: 34619491 DOI: 10.1016/j.jpsychires.2021.09.054] [Reference Citation Analysis]
193 Hamidi SH, Kadamboor Veethil S, Hamidi SH. Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective. Pharmacol Rep 2021;73:712-27. [PMID: 33880743 DOI: 10.1007/s43440-021-00255-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
194 Jeong SH, Kim YS. Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications. Clin Psychopharmacol Neurosci 2021;19:411-22. [PMID: 34294611 DOI: 10.9758/cpn.2021.19.3.411] [Reference Citation Analysis]
195 Quispe C, Cruz-Martins N, Manca ML, Manconi M, Sytar O, Hudz N, Shanaida M, Kumar M, Taheri Y, Martorell M, Sharifi-Rad J, Pintus G, Cho WC. Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases. Oxid Med Cell Longev 2021;2021:3149223. [PMID: 34584616 DOI: 10.1155/2021/3149223] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Townsend L, Dyer AH, Naughton A, Imangaliyev S, Dunne J, Kiersey R, Holden D, Mooney A, Leavy D, Ridge K, Sugrue J, Aldoseri M, Kelliher JH, Hennessy M, Byrne D, Browne P, Bacon CL, Doyle C, O’riordan R, Mclaughlin A, Bannan C, Martin-loeches I, White A, Mcloughlin RM, Bergin C, Bourke NM, O’farrelly C, Conlon N, Cheallaigh CN. Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression. Heliyon 2022;8:e09230. [DOI: 10.1016/j.heliyon.2022.e09230] [Reference Citation Analysis]
197 Roberts J, Pritchard AL, Treweeke AT, Rossi AG, Brace N, Cahill P, MacRury SM, Wei J, Megson IL. Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System. Front Cardiovasc Med 2020;7:629933. [PMID: 33614744 DOI: 10.3389/fcvm.2020.629933] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
198 Bussolari C, Palumbo D, Fominsky E, Nardelli P, De Lorenzo R, Vitali G, De Cobelli F, Rovere-Querini P, Scandroglio AM. Case Report: Nintedaninb May Accelerate Lung Recovery in Critical Coronavirus Disease 2019. Front Med (Lausanne) 2021;8:766486. [PMID: 34778326 DOI: 10.3389/fmed.2021.766486] [Reference Citation Analysis]
199 François S, Helissey C, Cavallero S, Drouet M, Libert N, Cosset JM, Deutsch E, Meziani L, Chargari C. COVID-19-Associated Pneumonia: Radiobiological Insights. Front Pharmacol 2021;12:640040. [PMID: 34113249 DOI: 10.3389/fphar.2021.640040] [Reference Citation Analysis]
200 Attiq A, Yao LJ, Afzal S, Khan MA. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19. Int Immunopharmacol 2021;101:108255. [PMID: 34688149 DOI: 10.1016/j.intimp.2021.108255] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
201 Rabiu Abubakar A, Ahmad R, Rowaiye AB, Rahman S, Iskandar K, Dutta S, Oli AN, Dhingra S, Tor MA, Etando A, Kumar S, Irfan M, Gowere M, Chowdhury K, Akter F, Jahan D, Schellack N, Haque M. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. Life 2022;12:478. [DOI: 10.3390/life12040478] [Reference Citation Analysis]
202 Arjmand B, Roudsari PP, Alavi-Moghadam S, Rezaei-Tavirani M, Tayanloo-Beik A, Mehrdad N, Adibi H, Larijani B. Potential for Stem Cell-Based Therapy in the Road of Treatment for Neurological Disorders Secondary to COVID-19. Regen Eng Transl Med 2021;:1-15. [PMID: 34746370 DOI: 10.1007/s40883-021-00234-x] [Reference Citation Analysis]
203 Di Gioacchino A, Šulc P, Komarova AV, Greenbaum BD, Monasson R, Cocco S. The heterogeneous landscape and early evolution of pathogen-associated CpG dinucleotides in SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32511407 DOI: 10.1101/2020.05.06.074039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Russo A, Tellone E, Barreca D, Ficarra S, Laganà G. Implication of COVID-19 on Erythrocytes Functionality: Red Blood Cell Biochemical Implications and Morpho-Functional Aspects. IJMS 2022;23:2171. [DOI: 10.3390/ijms23042171] [Reference Citation Analysis]
205 Kusi KA, Frimpong A, Partey FD, Lamptey H, Amoah LE, Ofori MF. High infectious disease burden as a basis for the observed high frequency of asymptomatic SARS-CoV-2 infections in sub-Saharan Africa. AAS Open Res 2021;4:2. [PMID: 34729457 DOI: 10.12688/aasopenres.13196.3] [Reference Citation Analysis]
206 Sammartino D, Jafri F, Cook B, La L, Kim H, Cardasis J, Raff J. Predictors for inpatient mortality during the first wave of the SARS-CoV-2 pandemic: A retrospective analysis. PLoS One 2021;16:e0251262. [PMID: 33970955 DOI: 10.1371/journal.pone.0251262] [Reference Citation Analysis]
207 Kumboyono K, Chomsy IN, Iskandar A, Aryati A, Parwati I, Wihastuti TA. The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival. IDR 2022;Volume 15:821-9. [DOI: 10.2147/idr.s348392] [Reference Citation Analysis]
208 Macdougall M, El-hajj Sleiman J, Beauchemin P, Rangachari M. SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation. Front Immunol 2022;13:871276. [DOI: 10.3389/fimmu.2022.871276] [Reference Citation Analysis]
209 Kar P, Saleh-E-In MM, Jaishee N, Anandraj A, Kormuth E, Vellingiri B, Angione C, Rahman PKSM, Pillay S, Sen A, Naidoo D, Roy A, Choi YE. Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19. J Cell Biochem 2022. [PMID: 35342986 DOI: 10.1002/jcb.30243] [Reference Citation Analysis]
210 Gutiérrez-Bautista JF, Rodriguez-Nicolas A, Rosales-Castillo A, López-Ruz MÁ, Martín-Casares AM, Fernández-Rubiales A, Anderson P, Garrido F, Ruiz-Cabello F, López-Nevot MÁ. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients. J Microbiol Immunol Infect 2021:S1684-1182(21)00183-3. [PMID: 34475005 DOI: 10.1016/j.jmii.2021.08.009] [Reference Citation Analysis]
211 Scholkmann F, Restin T, Ferrari M, Quaresima V. The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review. J Clin Med 2020;10:E50. [PMID: 33375707 DOI: 10.3390/jcm10010050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
212 Murdaca G, Di Gioacchino M, Greco M, Borro M, Paladin F, Petrarca C, Gangemi S. Basophils and Mast Cells in COVID-19 Pathogenesis. Cells 2021;10:2754. [PMID: 34685733 DOI: 10.3390/cells10102754] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Sengupta S, Handoo A, Pande R, Kapoor RK. Retrospective Analysis of Clinical Laboratory Parameters, Therapeutics and Outcome in Patients Infected with SARS-CoV2. Indian J Clin Biochem 2021;:1-7. [PMID: 34785872 DOI: 10.1007/s12291-021-01009-5] [Reference Citation Analysis]
214 Barone SM, Paul AGA, Muehling LM, Lannigan JA, Kwok WW, Turner RB, Woodfolk JA, Irish JM. Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy. bioRxiv 2020:2020. [PMID: 32766581 DOI: 10.1101/2020.07.31.190454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
215 Parvez MSA, Ohtsuki G. Acute Cerebellar Inflammation and Related Ataxia: Mechanisms and Pathophysiology. Brain Sciences 2022;12:367. [DOI: 10.3390/brainsci12030367] [Reference Citation Analysis]
216 Ligotti ME, Pojero F, Accardi G, Aiello A, Caruso C, Duro G, Candore G. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation? Front Cell Dev Biol 2021;9:725606. [PMID: 34595175 DOI: 10.3389/fcell.2021.725606] [Reference Citation Analysis]
217 Khani E, Khiali S, Entezari-Maleki T. Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review. J Clin Pharmacol 2021;61:429-60. [PMID: 33511638 DOI: 10.1002/jcph.1822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
218 Saini A, Oh TH, Ghanem DA, Castro M, Butler M, Sin Fai Lam CC, Posporelis S, Lewis G, David AS, Rogers JP. Inflammatory and blood gas markers of COVID-19 delirium compared to non-COVID-19 delirium: a cross-sectional study. Aging Ment Health 2021;:1-8. [PMID: 34651536 DOI: 10.1080/13607863.2021.1989375] [Reference Citation Analysis]
219 Huntington KE, Louie AD, Lee CG, Elias JA, Ross EA, El-Deiry WS. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2. Elife 2021;10:e64958. [PMID: 33443016 DOI: 10.7554/eLife.64958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
220 Lin A, Yan WH. Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection. Front Immunol 2021;12:788769. [PMID: 34938296 DOI: 10.3389/fimmu.2021.788769] [Reference Citation Analysis]
221 Elashiry M, Elsayed R, Elashiry MM, Rashid MH, Ara R, Arbab AS, Elawady AR, Hamrick M, Liu Y, Zhi W, Lucas R, Vazquez J, Cutler CW. Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung Diseases. Front Immunol 2021;12:636222. [PMID: 33841418 DOI: 10.3389/fimmu.2021.636222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
222 Das S, Pearson M, Taylor K, Bouchet V, Møller GL, Hall TO, Strivens M, Tzeng KTH, Gardner S. Combinatorial Analysis of Phenotypic and Clinical Risk Factors Associated With Hospitalized COVID-19 Patients. Front Digit Health 2021;3:660809. [PMID: 34713134 DOI: 10.3389/fdgth.2021.660809] [Reference Citation Analysis]
223 Melvin WJ, Audu CO, Davis FM, Sharma SB, Joshi A, DenDekker A, Wolf S, Barrett E, Mangum K, Zhou X, Bame M, Ruan A, Obi A, Kunkel SL, Moore BB, Gallagher KA. Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2. Proc Natl Acad Sci U S A 2021;118:e2101071118. [PMID: 34479991 DOI: 10.1073/pnas.2101071118] [Reference Citation Analysis]
224 Alavi Darazam I, Kazempour M, Pourhoseingholi MA, Hatami F, Rabiei MM, Javandoust Gharehbagh F, Amirdosara M, Hajiesmaeili M, Shabani M, Shokouhi S, Lotfollahi L, Mardani M, Haghighi-Morad M, Nassiri AA, Rangraz D, Falahaty H, Syami H, Irannejad Y, Fallah M, Zangi M, Shafigh N. Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19. Blood Purif 2022;:1-9. [PMID: 35580567 DOI: 10.1159/000524606] [Reference Citation Analysis]
225 Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol Neurobiol 2022. [PMID: 35028901 DOI: 10.1007/s12035-021-02696-0] [Reference Citation Analysis]
226 Abdelrahman Z, Chen Z, Lyu H, Wang X. Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis. Comput Struct Biotechnol J 2021;19:2347-55. [PMID: 33907612 DOI: 10.1016/j.csbj.2021.04.043] [Reference Citation Analysis]
227 Garg SS, Sharma A, Gupta J. Immunomodulation and immunotherapeutics of COVID-19. Clin Immunol 2021;231:108842. [PMID: 34461289 DOI: 10.1016/j.clim.2021.108842] [Reference Citation Analysis]
228 Shrivastava R, Vijay M, Maneby N, Shrivastava R. Clinical Efficacy of an Osmotic, Antiviral and Anti-Inflammatory Polymeric Nasal Film to Treat Covid-19 Early-Phase Respiratory Symptoms. OAJCT 2021;Volume 13:11-20. [DOI: 10.2147/oajct.s307144] [Reference Citation Analysis]
229 Çekmen B. Comparison of demographic and laboratory data of young and elderly patients who deceased due to COVID-19. Journal of Health Sciences and Medicine 2022;5:478-81. [DOI: 10.32322/jhsm.1047413] [Reference Citation Analysis]
230 Rajaiah R, Abhilasha KV, Shekar MA, Vogel SN, Vishwanath BS. Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19. Cell Immunol 2020;358:104240. [PMID: 33137649 DOI: 10.1016/j.cellimm.2020.104240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
231 Chen G, Liao Q, Ai J, Yang B, Bai H, Chen J, Liu F, Cao Y, Liu H, Li K. Immune Response to COVID-19 During Pregnancy. Front Immunol 2021;12:675476. [PMID: 34012458 DOI: 10.3389/fimmu.2021.675476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
232 Sindelar M, Stancliffe E, Schwaiger-Haber M, Anbukumar DS, Adkins-Travis K, Goss CW, O'Halloran JA, Mudd PA, Liu WC, Albrecht RA, García-Sastre A, Shriver LP, Patti GJ. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med 2021;2:100369. [PMID: 34308390 DOI: 10.1016/j.xcrm.2021.100369] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Patil P, Shetty P, Kuriakose N, Gollapalli P, Shetty S, Bhandary R, Vishwanatha JK, Ghate SD. Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications. Int J Mol Sci 2021;22:11028. [PMID: 34681689 DOI: 10.3390/ijms222011028] [Reference Citation Analysis]
234 Park M, Kim H, Kim S, Lee J, Kim S, Byun JW, Hwang-Bo J, Park KH. Changes in skin wrinkles and pores due to long-term mask wear. Skin Res Technol 2021;27:785-8. [PMID: 33638266 DOI: 10.1111/srt.13019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Pan T, Chen R, He X, Yuan Y, Deng X, Li R, Yan H, Yan S, Liu J, Zhang Y, Zhang X, Yu F, Zhou M, Ke C, Ma X, Zhang H. Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route. Signal Transduct Target Ther 2021;6:420. [PMID: 34907154 DOI: 10.1038/s41392-021-00848-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Diab AM, Carleton BC, Goralski KB. COVID-19 pathophysiology and pharmacology: what do we know and how did Canadians respond? A review of Health Canada authorized clinical vaccine and drug trials. Can J Physiol Pharmacol 2021;99:577-88. [PMID: 33852809 DOI: 10.1139/cjpp-2021-0038] [Reference Citation Analysis]
237 Khan A, Rao TS, Joshi HM. Phage therapy in the Covid-19 era: Advantages over antibiotics. Curr Res Microb Sci 2022;:100115. [PMID: 35187507 DOI: 10.1016/j.crmicr.2022.100115] [Reference Citation Analysis]
238 Chouw A, Milanda T, Sartika CR, Kirana MN, Halim D, Faried A. Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19. Regen Eng Transl Med 2021;:1-12. [PMID: 33723519 DOI: 10.1007/s40883-021-00202-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
239 Mahrooz A, Muscogiuri G, Buzzetti R, Maddaloni E. The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism. Endocrine 2021;72:317-25. [PMID: 33886062 DOI: 10.1007/s12020-021-02729-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Alexandrova R, Beykov P, Vassilev D, Jukić M, Podlipnik Č. The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19. Biotechnology & Biotechnological Equipment 2021;35:74-102. [DOI: 10.1080/13102818.2020.1847683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
241 Cazzola M, Rogliani P, Salvi SS, Ora J, Matera MG. Use of Thiols in the Treatment of COVID-19: Current Evidence. Lung 2021;199:335-43. [PMID: 34448938 DOI: 10.1007/s00408-021-00465-3] [Reference Citation Analysis]
242 Sutradhar J, Sarkar BR. The Effect on the Immune System in the Human Body Due to COVID-19: An Insight on Traditional to Modern Approach as a Preventive Measure. J Pharmacopuncture 2021;24:165-72. [PMID: 35028167 DOI: 10.3831/KPI.2021.24.4.165] [Reference Citation Analysis]
243 Lim J, Puan KJ, Wang LW, Teng KWW, Loh CY, Tan KP, Carissimo G, Chan YH, Poh CM, Lee CY, Fong SW, Yeo NK, Chee RS, Amrun SN, Chang ZW, Tay MZ, Torres-Ruesta A, Leo Fernandez N, How W, Andiappan AK, Lee W, Duan K, Tan SY, Yan G, Kalimuddin S, Lye DC, Leo YS, Ong SWX, Young BE, Renia L, Ng LFP, Lee B, Rötzschke O. Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals. Front Immunol 2021;12:710217. [PMID: 34867943 DOI: 10.3389/fimmu.2021.710217] [Reference Citation Analysis]
244 Macela A, Kubelkova K. Why Does SARS-CoV-2 Infection Induce Autoantibody Production? Pathogens 2021;10:380. [PMID: 33809954 DOI: 10.3390/pathogens10030380] [Reference Citation Analysis]
245 Abdelnaby H, Aboelhassan W, Al-Jarallah M, Rajan R, Dashti R, Zhanna KD, Alsaber AR, Abd El-Aleem A, Ashry I, Abdullah M, Mahmoud Fouad A. Outcomes of tocilizumab therapy in severe or critical COVID-19 patients: A retrospective cohort, single-centre study. Trop Med Int Health 2021. [PMID: 34601803 DOI: 10.1111/tmi.13685] [Reference Citation Analysis]
246 Mélo Silva Júnior ML, Souza LMA, Dutra REMC, Valente RGM, Melo TS. Review on therapeutic targets for COVID-19: insights from cytokine storm. Postgrad Med J 2021;97:391-8. [PMID: 33008960 DOI: 10.1136/postgradmedj-2020-138791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
247 Mester A, Benedek I, Rat N, Tolescu C, Polexa SA, Benedek T. Imaging Cardiovascular Inflammation in the COVID-19 Era. Diagnostics (Basel) 2021;11:1114. [PMID: 34207266 DOI: 10.3390/diagnostics11061114] [Reference Citation Analysis]
248 Di Pompo G, Errani C, Gillies R, Mercatali L, Ibrahim T, Tamanti J, Baldini N, Avnet S. Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis. Front Cell Dev Biol 2021;9:678532. [PMID: 34124067 DOI: 10.3389/fcell.2021.678532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
249 Zhang Z, Zhang X, Bi K, He Y, Yan W, Yang CS, Zhang J. Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. Trends Food Sci Technol 2021;114:11-24. [PMID: 34054222 DOI: 10.1016/j.tifs.2021.05.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
250 Calu V, Ionescu A, Stanca L, Geicu OI, Iordache F, Pisoschi AM, Serban AI, Bilteanu L. Key biomarkers within the colorectal cancer related inflammatory microenvironment. Sci Rep 2021;11:7940. [PMID: 33846436 DOI: 10.1038/s41598-021-86941-5] [Reference Citation Analysis]
251 Kverno K. Brain Fog: A Bit of Clarity Regarding Etiology, Prognosis, and Treatment. J Psychosoc Nurs Ment Health Serv 2021;59:9-13. [PMID: 34714198 DOI: 10.3928/02793695-20211013-01] [Reference Citation Analysis]
252 Ozgür D, Karamese M, Medetalibeyoglu A, Alkan O, Senkal N, Tutuncu EE. High Levels of Circulating IL-6 and IL-8 Signature can Predict COVID-19 Severity. Jundishapur J Microbiol 2021;14. [DOI: 10.5812/jjm.119060] [Reference Citation Analysis]
253 Yin J, Li C, Ye C, Ruan Z, Liang Y, Li Y, Wu J, Luo Z. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.026] [Reference Citation Analysis]
254 Wassenaar TM, Buzard GS, Newman DJ. BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data. Lett Appl Microbiol 2020;71:498-505. [PMID: 32734625 DOI: 10.1111/lam.13365] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
255 Schwarz Y, Percik R, Oberman B, Yaffe D, Zimlichman E, Tirosh A. Sick Euthyroid Syndrome on Presentation of Patients With COVID-19: A Potential Marker for Disease Severity. Endocr Pract 2021;27:101-9. [PMID: 33551316 DOI: 10.1016/j.eprac.2021.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
256 Chen S, Wang X, Ha D, Yoshitake R. White Button Mushroom (Agaricus bisporus) Interrupts Tissue AR-TMPRSS2 Expression and Attenuates Pro-inflammatory Cytokines in C57BL/6 Mice: Implication for COVID-19 Dietary Intervention. Res Sq 2021:rs. [PMID: 33791688 DOI: 10.21203/rs.3.rs-244245/v1] [Reference Citation Analysis]
257 Fijen LM, Grefhorst A, Levels JHM, Cohn DM. Severe acquired hypertriglyceridemia following COVID-19. BMJ Case Rep 2021;14:e246698. [PMID: 34764129 DOI: 10.1136/bcr-2021-246698] [Reference Citation Analysis]
258 Vázquez-Jiménez A, Avila-Ponce De León UE, Matadamas-Guzman M, Muciño-Olmos EA, Martínez-López YE, Escobedo-Tapia T, Resendis-Antonio O. On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers. Front Immunol 2021;12:705646. [PMID: 34603282 DOI: 10.3389/fimmu.2021.705646] [Reference Citation Analysis]
259 Tang X, Cai L, Meng Y, Xu J, Lu C, Yang J. Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19. Front Immunol 2020;11:603615. [PMID: 33584672 DOI: 10.3389/fimmu.2020.603615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
260 Farnoosh G, Akbariqomi M, Badri T, Bagheri M, Izadi M, Saeedi-Boroujeni A, Rezaie E, Ghaleh HEG, Aghamollaei H, Fasihi-Ramandi M, Hassanpour K, Alishiri G. Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial. Arch Med Res 2021:S0188-4409(21)00141-7. [PMID: 34229896 DOI: 10.1016/j.arcmed.2021.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Sharma P, Pandey AK, Bhattacharyya DK. Determining crucial genes associated with COVID-19 based on COPD Findings✶,✶✶. Comput Biol Med 2021;128:104126. [PMID: 33260035 DOI: 10.1016/j.compbiomed.2020.104126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
262 Cruz-Teran C, Tiruthani K, McSweeney M, Ma A, Pickles R, Lai SK. Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy. Adv Drug Deliv Rev 2021;169:100-17. [PMID: 33309815 DOI: 10.1016/j.addr.2020.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
263 Toor SM, Saleh R, Sasidharan Nair V, Taha RZ, Elkord E. T-cell responses and therapies against SARS-CoV-2 infection. Immunology 2021;162:30-43. [PMID: 32935333 DOI: 10.1111/imm.13262] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
264 Khursheed A, Jain V, Rasool A, Rather MA, Malik NA, Shalla AH. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies. Microb Pathog 2021;157:104933. [PMID: 33984466 DOI: 10.1016/j.micpath.2021.104933] [Reference Citation Analysis]
265 Shariq M, Sheikh JA, Quadir N, Sharma N, Hasnain SE, Ehtesham NZ. COVID-19 and tuberculosis: the double whammy of respiratory pathogens. Eur Respir Rev 2022;31:210264. [PMID: 35418488 DOI: 10.1183/16000617.0264-2021] [Reference Citation Analysis]
266 Kumar V, Kumar R, Kumar M, Wander GS, Gupta V, Sahani A. Recent advances in low-cost, portable automated resuscitator systems to fight COVID-19. Health Technol (Berl) 2021;:1-11. [PMID: 34873565 DOI: 10.1007/s12553-021-00629-4] [Reference Citation Analysis]
267 Al-Kuraishy HM, Al-Gareeb AI, Faidah H, Al-Maiahy TJ, Cruz-Martins N, Batiha GE. The Looming Effects of Estrogen in Covid-19: A Rocky Rollout. Front Nutr 2021;8:649128. [PMID: 33816542 DOI: 10.3389/fnut.2021.649128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
268 Liu BM, Hill HR. Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review.J Interferon Cytokine Res. 2020;40:549-554. [PMID: 33337932 DOI: 10.1089/jir.2020.0210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
269 Dickel S, Grimm C, Amschler K, Schnitzler SU, Schanz J, Moerer O, Payen D, Tampe B, Winkler MS. Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome. Front Immunol 2021;12:645124. [PMID: 33897692 DOI: 10.3389/fimmu.2021.645124] [Reference Citation Analysis]
270 Crooke PS 3rd, Tossberg JT, Porter KP, Aune TM. Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease. J Immunol 2021;206:1691-6. [PMID: 33782089 DOI: 10.4049/jimmunol.2001428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
271 Melin AD, Janiak MC, Marrone F 3rd, Arora PS, Higham JP. Comparative ACE2 variation and primate COVID-19 risk. bioRxiv 2020:2020. [PMID: 32511330 DOI: 10.1101/2020.04.09.034967] [Cited by in Crossref: 20] [Cited by in F6Publishing: 2] [Article Influence: 10.0] [Reference Citation Analysis]
272 Kozma GT, Mészáros T, Bakos T, Hennies M, Bencze D, Uzonyi B, Győrffy B, Cedrone E, Dobrovolskaia MA, Józsi M, Szebeni J. Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm. Front Immunol 2021;12:642860. [PMID: 33995361 DOI: 10.3389/fimmu.2021.642860] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
273 Dhar SK, K V, Damodar S, Gujar S, Das M. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon 2021;7:e06155. [PMID: 33553782 DOI: 10.1016/j.heliyon.2021.e06155] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
274 Morozov VA, Morozov AV. A Comprehensive Analysis of Human Endogenous Retroviruses HERV-K (HML.2) from Teratocarcinoma Cell Lines and Detection of Viral Cargo in Microvesicles. Int J Mol Sci 2021;22:12398. [PMID: 34830279 DOI: 10.3390/ijms222212398] [Reference Citation Analysis]
275 Llamas M, Garo ML, Giovanella L. Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis. Clin Chem Lab Med 2021. [PMID: 34380183 DOI: 10.1515/cclm-2021-0805] [Reference Citation Analysis]
276 Patel S, Saxena B, Mehta P. Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19. Heliyon 2021;7:e06158. [PMID: 33553708 DOI: 10.1016/j.heliyon.2021.e06158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
277 Puzyrenko A, Felix JC, Sun Y, Rui H, Sheinin Y. Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature. Pathol Res Pract 2021;220:153380. [PMID: 33676105 DOI: 10.1016/j.prp.2021.153380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Rahbar M, Wu Y, Subramony JA, Liu G. Sensitive Colorimetric Detection of Interleukin-6 via Lateral Flow Assay Incorporated Silver Amplification Method. Front Bioeng Biotechnol 2021;9:778269. [PMID: 34900966 DOI: 10.3389/fbioe.2021.778269] [Reference Citation Analysis]
279 Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA. The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol 2021;87:104647. [PMID: 33264669 DOI: 10.1016/j.meegid.2020.104647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
280 Forqué L, Albert E, Giménez E, Torres I, Carbonell N, Ferreres J, Blasco ML, Navarro D. Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: May it help to predict clinical outcomes? Journal of Clinical Virology 2022;148:105082. [DOI: 10.1016/j.jcv.2022.105082] [Reference Citation Analysis]
281 Tuma RL, Guedes BF, Carra R, Iepsen B, Rodrigues J, Camelo-Filho AE, Kubota G, Ferrari M, Studart-Neto A, Oku MH, Terrim S, Lopes CCB, Passos Neto CEB, Fiorentino MD, Souza JCC, Baima JPS, Silva T, Perissinotti I, Martin MDGM, Gonçalves M, Fortini I, Smid J, Adoni T, Lucato L, Nitrini R, Gomes H, Castro LH. Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series. Neurol Sci 2021;42:479-89. [PMID: 33409828 DOI: 10.1007/s10072-020-04946-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
282 Murugan AK, Alzahrani AS. SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases. J Inflamm Res 2021;14:6191-221. [PMID: 34853527 DOI: 10.2147/JIR.S332705] [Reference Citation Analysis]
283 Bortot B, Romani A, Ricci G, Biffi S. Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19. Front Pharmacol 2022;13:877422. [DOI: 10.3389/fphar.2022.877422] [Reference Citation Analysis]
284 Jansen van Vuren E, Steyn SF, Brink CB, Möller M, Viljoen FP, Harvey BH. The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment. Biomed Pharmacother 2021;135:111200. [PMID: 33421734 DOI: 10.1016/j.biopha.2020.111200] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
285 Frankel AE, Reddy R, DeSuza KR, Deeb K, Carlin AF, Smith D, Xie Y, Naik E, Silver RT, Hasselbalch HC. Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib. Clin Case Rep 2021;9:2228-35. [PMID: 33936671 DOI: 10.1002/ccr3.3997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
286 García de Guadiana-Romualdo L, Rodríguez Rojas C, Morell-García D, Andaluz-Ojeda D, Rodríguez Mulero MD, Rodríguez-Borja E, Ballesteros-Vizoso A, Calvo MD, Albert-Botella L, Pozo Giráldez A, Llompart-Alabern I, Bolado Jiménez C, Hernández Olivo M, Fernández Presa L, Ortega-Pérez J, Fora Romero MJ, Campos-Rodríguez V, Ballester Férriz A, Guiu-Martí AM, Pinilla Arribas L, Galindo Martínez M, Puerto-Lara ER, López Tarazaga AB, Ros Braquehais MS, Nogales Martín L, Juez Santamaría C, Trapiello Fernández W, Espinilla Fernández V, Havelka A, Albaladejo-Otón MD. Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study). Inflamm Res 2021. [PMID: 34718856 DOI: 10.1007/s00011-021-01516-4] [Reference Citation Analysis]
287 Magdy R, Hussein M, Ragaie C, Abdel-Hamid HM, Khallaf A, Rizk HI, Dahshan A. Characteristics of headache attributed to COVID-19 infection and predictors of its frequency and intensity: A cross sectional study. Cephalalgia 2020;40:1422-31. [PMID: 33146038 DOI: 10.1177/0333102420965140] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
288 Karampoor S, Zahednasab H, Farahmand M, Mirzaei R, Zamani F, Tabibzadeh A, Bouzari B, Ajdarkosh H, Nikkhah M, Hashemi MR, Laali A, Keyvani H. A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19). Int Immunopharmacol 2021;97:107684. [PMID: 33932696 DOI: 10.1016/j.intimp.2021.107684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
289 Tomlinson KL, Prince AS, Wong Fok Lung T. Immunometabolites Drive Bacterial Adaptation to the Airway. Front Immunol 2021;12:790574. [PMID: 34899759 DOI: 10.3389/fimmu.2021.790574] [Reference Citation Analysis]
290 Vassiliadi DA, Vassiliou AG, Ilias I, Tsagarakis S, Kotanidou A, Dimopoulou I. Pituitary-Adrenal Responses and Glucocorticoid Receptor Expression in Critically Ill Patients with COVID-19. Int J Mol Sci 2021;22:11473. [PMID: 34768903 DOI: 10.3390/ijms222111473] [Reference Citation Analysis]
291 Vignesh R, Swathirajan CR, Tun ZH, Rameshkumar MR, Solomon SS, Balakrishnan P. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm? Front Immunol 2020;11:607734. [PMID: 33569053 DOI: 10.3389/fimmu.2020.607734] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
292 Ak R, Doğanay F, Yilmaz E. Comparison of C-reactive protein and C-reactive protein-to-albumin ratio in predicting mortality among geriatric coronavirus disease 2019 patients. Rev Assoc Med Bras (1992) 2021:S0104-42302021005012204. [PMID: 34909968 DOI: 10.1590/1806-9282.20210811] [Reference Citation Analysis]
293 Ruetsch C, Brglez V, Crémoni M, Zorzi K, Fernandez C, Boyer-Suavet S, Benzaken S, Demonchy E, Risso K, Courjon J, Cua E, Ichai C, Dellamonica J, Passeron T, Seitz-Polski B. Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients. Front Med (Lausanne) 2020;7:603961. [PMID: 33585507 DOI: 10.3389/fmed.2020.603961] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
294 Italia L, Tomasoni D, Bisegna S, Pancaldi E, Stretti L, Adamo M, Metra M. COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae. Front Cardiovasc Med 2021;8:713560. [PMID: 34447795 DOI: 10.3389/fcvm.2021.713560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
295 Al-Rasheedi M, Alhazmi Y, Almaqwashi N, Mateq Ali A, Kardam A, Sharaf M, Haider KH. Corticosteroid therapy for 2019-nCoV-infected patients: A case series of eight mechanically ventilated patients. Clin Case Rep 2021;9:e04066. [PMID: 34084491 DOI: 10.1002/ccr3.4066] [Reference Citation Analysis]
296 Srivastava M, Hall D, Omoru OB, Gill HM, Smith S, Janga SC. Mutational Landscape and Interaction of SARS-CoV-2 with Host Cellular Components. Microorganisms 2021;9:1794. [PMID: 34576690 DOI: 10.3390/microorganisms9091794] [Reference Citation Analysis]
297 Khandelwal A, Singh GP, Rath GP, Chaturvedi A. The "COVID-19 Score" can predict the need for tracheal intubation in critically ill COVID-19 patients - A hypothesis. Med Hypotheses 2020;144:110292. [PMID: 33254485 DOI: 10.1016/j.mehy.2020.110292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
298 Grant AH, Estrada A 3rd, Ayala-Marin YM, Alvidrez-Camacho AY, Rodriguez G, Robles-Escajeda E, Cadena-Medina DA, Rodriguez AC, Kirken RA. The Many Faces of JAKs and STATs Within the COVID-19 Storm. Front Immunol 2021;12:690477. [PMID: 34326843 DOI: 10.3389/fimmu.2021.690477] [Reference Citation Analysis]
299 Shi Z, Puyo CA. N-Acetylcysteine to Combat COVID-19: An Evidence Review. Ther Clin Risk Manag 2020;16:1047-55. [PMID: 33177829 DOI: 10.2147/TCRM.S273700] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
300 Mishra SK, Tripathi T. One year update on the COVID-19 pandemic: Where are we now? Acta Trop 2021;214:105778. [PMID: 33253656 DOI: 10.1016/j.actatropica.2020.105778] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
301 Selvarajan RS, Gopinath SCB, Zin NM, Hamzah AA. Infection-Mediated Clinical Biomarkers for a COVID-19 Electrical Biosensing Platform. Sensors (Basel) 2021;21:3829. [PMID: 34205852 DOI: 10.3390/s21113829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
303 Wang X, Ha D, Yoshitake R, Chen S. White button mushroom interrupts tissue AR-mediated TMPRSS2 expression and attenuates pro-inflammatory cytokines in C57BL/6 mice. NPJ Sci Food 2021;5:20. [PMID: 34341347 DOI: 10.1038/s41538-021-00102-6] [Reference Citation Analysis]
304 Tsoukalas D, Sarandi E, Georgaki S. The snapshot of metabolic health in evaluating micronutrient status, the risk of infection and clinical outcome of COVID-19. Clin Nutr ESPEN 2021;44:173-87. [PMID: 34330463 DOI: 10.1016/j.clnesp.2021.06.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
305 He S, Gui J, Xiong K, Chen M, Gao H, Fu Y. A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases. J Nanobiotechnology 2022;20:101. [PMID: 35241085 DOI: 10.1186/s12951-022-01307-x] [Reference Citation Analysis]
306 Sen R, Garbati M, Bryant K, Lu Y. Epigenetic mechanisms influencing COVID-19. Genome 2021;64:372-85. [PMID: 33395363 DOI: 10.1139/gen-2020-0135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
307 Heydarian M, Mohammadtaghizadeh M, Shojaei M, Babazadeh M, Abbasian S, Amrovani M. The effect of COVID-19 derived cytokine storm on cancer cells progression: double-edged sword. Mol Biol Rep 2021. [PMID: 34657251 DOI: 10.1007/s11033-021-06800-4] [Reference Citation Analysis]
308 El-shabrawy M, Alsadik ME, El-shafei M, Abdelmoaty AA, Alazzouni AS, Esawy MM, Shabana MA. Interleukin-6 and C-reactive protein/albumin ratio as predictors of COVID-19 severity and mortality. Egypt J Bronchol 2021;15. [DOI: 10.1186/s43168-021-00054-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
309 Dayarathna S, Jeewandara C, Gomes L, Somathilaka G, Jayathilaka D, Vimalachandran V, Wijewickrama A, Narangoda E, Idampitiya D, Ogg GS, Malavige GN. Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19. Sci Rep 2020;10:19839. [PMID: 33199778 DOI: 10.1038/s41598-020-76836-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
310 Yang A, Guduguntla LS, Yang B. Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19. J Cell Immunol 2020;2:333-40. [PMID: 33426541 DOI: 10.33696/immunology.2.063] [Reference Citation Analysis]
311 Quan Y, Li L, Yin Z, Chen S, Yi J, Lang J, Zhang L, Yue Q, Zhao J. Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19? Front Pharmacol 2022;12:784335. [DOI: 10.3389/fphar.2021.784335] [Reference Citation Analysis]
312 Hertzog RG, Bicheru NS, Popescu DM, Călborean O, Catrina AM. Hypoxic preconditioning - A nonpharmacological approach in COVID-19 prevention. Int J Infect Dis 2021;103:415-9. [PMID: 33249285 DOI: 10.1016/j.ijid.2020.11.181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
313 Ciechanowicz P, Lewandowski K, Szymańska E, Kaniewska M, Rydzewska GM, Walecka I. Skin and gastrointestinal symptoms in COVID-19. Prz Gastroenterol 2020;15:301-8. [PMID: 33777269 DOI: 10.5114/pg.2020.101558] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
314 Gilham D, Smith AL, Fu L, Moore DY, Muralidharan A, Reid SPM, Stotz SC, Johansson JO, Sweeney M, Wong NCW, Kulikowski E, El-Gamal D. Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro. Biomedicines 2021;9:437. [PMID: 33919584 DOI: 10.3390/biomedicines9040437] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
315 Sarohan AR, Kızıl M, İnkaya AÇ, Mahmud S, Akram M, Cen O. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder. Cell Signal 2021;87:110121. [PMID: 34438017 DOI: 10.1016/j.cellsig.2021.110121] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Peter AE, Sandeep BV, Rao BG, Kalpana VL. Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19. Front Pharmacol 2020;11:583777. [PMID: 33708109 DOI: 10.3389/fphar.2020.583777] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
317 Raghavan S, Kenchappa DB, Leo MD. SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity. Front Cardiovasc Med 2021;8:687783. [PMID: 34179146 DOI: 10.3389/fcvm.2021.687783] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
318 Chang R, Mamun A, Dominic A, Le NT. SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress. Front Physiol 2020;11:605908. [PMID: 33519510 DOI: 10.3389/fphys.2020.605908] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
319 Knowlton KU. Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus. J Mol Cell Cardiol 2020;147:12-7. [PMID: 32771409 DOI: 10.1016/j.yjmcc.2020.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
320 Garcia-Carretero R, Vazquez-Gomez O, Ordoñez-Garcia M. Delayed Immune Reconstitution Inflammatory Syndrome in an Immunosuppressed Patient With SARS-CoV-2. Cureus 2021;13:e19481. [PMID: 34912622 DOI: 10.7759/cureus.19481] [Reference Citation Analysis]
321 Zhang Y, Yao F, Kuang X, Li L, Huang L, Zhou Q, Peng J, Chang Q. How Can Alternative Exercise Traditions Help Against the Background of the COVID-19 in Cancer Care? An Overview of Systematic Reviews. Cancer Manag Res 2020;12:12927-44. [PMID: 33363409 DOI: 10.2147/CMAR.S282491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
322 Jafarzadeh A, Nemati M, Jafarzadeh S. Contribution of STAT3 to the pathogenesis of COVID-19. Microb Pathog 2021;154:104836. [PMID: 33691172 DOI: 10.1016/j.micpath.2021.104836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
323 Alamri A, Fisk D, Upreti D, Kung SKP. A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections. Int J Mol Sci 2021;22:1118. [PMID: 33498725 DOI: 10.3390/ijms22031118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
324 Mazzaccaro D, Dolci M, Perego F, Delbue S, Giannetta M, Cardani R, Valentina Renna L, Costa E, Corsi-Romanelli MM, Galli C, Pariani E, Nano G, Clemente C, Basilico N. VIRAL AGENTS AND SYSTEMIC LEVELS OF INFLAMMATORY CYTOKINES IN VULNERABLE AND STABLE ATHEROSCLEROTIC CAROTID PLAQUES. Ann Vasc Surg 2021:S0890-5096(21)00912-2. [PMID: 34902464 DOI: 10.1016/j.avsg.2021.10.070] [Reference Citation Analysis]
325 Theoharides TC. Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder. J Pers Med 2021;11:860. [PMID: 34575637 DOI: 10.3390/jpm11090860] [Reference Citation Analysis]
326 Wu J, Sun B, Hou L, Guan F, Wang L, Cheng P, Scobell S, Cheng YC, Lam W. Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China. Front Pharmacol 2020;11:615287. [PMID: 33716728 DOI: 10.3389/fphar.2020.615287] [Reference Citation Analysis]
327 Hong SY, Lansky E, Kang SS, Yang M. A review of pears (Pyrus spp.), ancient functional food for modern times. BMC Complement Med Ther 2021;21:219. [PMID: 34470625 DOI: 10.1186/s12906-021-03392-1] [Reference Citation Analysis]
328 Vaira LA, De Vito A, Deiana G, Pes C, Giovanditto F, Fiore V, Lechien JR, Le Bon SD, Saussez S, Madeddu G, Babudieri S, Pazzola A, Bandiera F, Fois AG, Piana AF, Hopkins C, De Riu G. Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study. Eur Arch Otorhinolaryngol 2021. [PMID: 33983525 DOI: 10.1007/s00405-021-06868-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
329 Li Y, Xu Z, Lei Q, Lai DY, Hou H, Jiang HW, Zheng YX, Wang XN, Wu J, Ma ML, Zhang B, Chen H, Yu C, Xue JB, Zhang HN, Qi H, Guo SJ, Zhang Y, Lin X, Yao Z, Sheng H, Sun Z, Wang F, Fan X, Tao SC. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins. Cell Rep 2021;36:109391. [PMID: 34242574 DOI: 10.1016/j.celrep.2021.109391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
330 Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021;14:1487-510. [PMID: 33889008 DOI: 10.2147/JIR.S301784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
331 Nejatifard M, Asefi S, Jamali R, Hamblin MR, Fekrazad R. Probable positive effects of the photobiomodulation as an adjunctive treatment in COVID-19: A systematic review. Cytokine 2021;137:155312. [PMID: 33128927 DOI: 10.1016/j.cyto.2020.155312] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
332 Manosso LM, Arent CO, Borba LA, Ceretta LB, Quevedo J, Réus GZ. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection. Cells 2021;10:1993. [PMID: 34440767 DOI: 10.3390/cells10081993] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
333 Elekhnawy E, Negm WA. The potential application of probiotics for the prevention and treatment of COVID-19. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00252-6] [Reference Citation Analysis]
334 Kilcoyne A, Jordan E, Thomas K, Pepper AN, Zhou A, Chappell D, Amarapala M, Thériault R, Thompson M. Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England. CEOR 2022;Volume 14:231-47. [DOI: 10.2147/ceor.s360741] [Reference Citation Analysis]
335 Porto BN, Moraes TJ. The triad: respiratory microbiome - virus - immune response in the pathophysiology of pulmonary viral infections. Expert Rev Respir Med 2021;15:635-48. [PMID: 33605840 DOI: 10.1080/17476348.2021.1893168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 El Abd Y, Tabll A, Smolic R, Smolic M. Mini-review: The market growth of diagnostic and therapeutic monoclonal antibodies - SARS CoV-2 as an example. Hum Antibodies 2022;30:15-24. [PMID: 34958012 DOI: 10.3233/HAB-211513] [Reference Citation Analysis]
337 Abdelhamid MHM, Fellah AA, Elmarghani A, Al Msellati IA. An Assessment of Men Semen Alterations in SARS-CoV-2: Is Fever the Principal Concern? Reprod Sci 2022. [PMID: 35194760 DOI: 10.1007/s43032-022-00889-z] [Reference Citation Analysis]
338 Arazi H, Falahati A, Suzuki K. Moderate Intensity Aerobic Exercise Potential Favorable Effect Against COVID-19: The Role of Renin-Angiotensin System and Immunomodulatory Effects. Front Physiol 2021;12:747200. [PMID: 34867452 DOI: 10.3389/fphys.2021.747200] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
339 Erukainure OL, Matsabisa MG, Muhammad A, Abarshi MM, Amaku JF, Katsayal SB, Nde AL. Targeting of Protein's Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of Cannabis Sativa L. Front Pharmacol 2021;12:736511. [PMID: 34539415 DOI: 10.3389/fphar.2021.736511] [Reference Citation Analysis]
340 Mouffak S, Shubbar Q, Saleh E, El-Awady R. Recent advances in management of COVID-19: A review. Biomed Pharmacother 2021;143:112107. [PMID: 34488083 DOI: 10.1016/j.biopha.2021.112107] [Reference Citation Analysis]
341 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
342 Soni B, Singh S. COVID-19 co-infection mathematical model as guided through signaling structural framework. Comput Struct Biotechnol J 2021;19:1672-83. [PMID: 33815692 DOI: 10.1016/j.csbj.2021.03.028] [Reference Citation Analysis]
343 Dye C, Lenz KM, Leuner B. Immune System Alterations and Postpartum Mental Illness: Evidence From Basic and Clinical Research. Front Glob Womens Health 2022;2:758748. [DOI: 10.3389/fgwh.2021.758748] [Reference Citation Analysis]
344 Corrao S, Mallaci Bocchio R, Lo Monaco M, Natoli G, Cavezzi A, Troiani E, Argano C. Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc. Nutrients 2021;13:1261. [PMID: 33921297 DOI: 10.3390/nu13041261] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
345 Mendivil CO. Dietary Fish, Fish Nutrients, and Immune Function: A Review. Front Nutr 2020;7:617652. [PMID: 33553231 DOI: 10.3389/fnut.2020.617652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
346 Landstra CP, de Koning EJP. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front Endocrinol (Lausanne) 2021;12:649525. [PMID: 34220706 DOI: 10.3389/fendo.2021.649525] [Reference Citation Analysis]
347 Yang Y, Cai Z, Zhang J. Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-analysis. Biosci Rep 2021;41:BSR20203584. [PMID: 33480978 DOI: 10.1042/BSR20203584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
348 Lewiecki EM. Vitamin D and COVID-19: Is something better than nothing? Osteoporos Sarcopenia 2020;6:95-6. [PMID: 32901226 DOI: 10.1016/j.afos.2020.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
349 Law MF, Ho R, Law KWT, Cheung CKM. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases. World J Hepatol 2021; 13(12): 1850-1874 [DOI: 10.4254/wjh.v13.i12.1850] [Reference Citation Analysis]
350 Qin R, He L, Yang Z, Jia N, Chen R, Xie J, Fu W, Chen H, Lin X, Huang R, Luo T, Liu Y, Yao S, Jiang M, Li J. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis. Clin Rev Allergy Immunol 2022. [PMID: 35040086 DOI: 10.1007/s12016-021-08908-8] [Reference Citation Analysis]
351 Hussein M, Fathy W, Eid RA, Abdel-Hamid HM, Yehia A, Sheemy MS, Ragaie C, Dahshan A, Rizk HI, Laz N, Magdy R. Relative Frequency and Risk Factors of COVID-19 Related Headache in a Sample of Egyptian Population: A Hospital-Based Study. Pain Med 2021;22:2092-9. [PMID: 33544857 DOI: 10.1093/pm/pnab020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
352 Sunkara H, Dewan SMR. Coronavirus disease-2019: A review on the disease exacerbation via cytokine storm and concurrent management. Int Immunopharmacol 2021;99:108049. [PMID: 34426104 DOI: 10.1016/j.intimp.2021.108049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Khitan ZJ, Khawaja I, Mufson MA, Sanabria JR, Abraham NG, Peterson SJ, Sundaram U, Shapiro JI. Can charcoal improve outcomes in COVID-19 infections? Med Hypotheses 2020;144:110176. [PMID: 33254498 DOI: 10.1016/j.mehy.2020.110176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
354 Haskologlu IC, Erdag E, Sayiner S, Abacioglu N, Sehirli AO. Melatonin and REGN-CoV2 combination as a vaccine adjuvant for Omicron variant of SARS-CoV-2. Mol Biol Rep 2022. [PMID: 35389130 DOI: 10.1007/s11033-022-07419-9] [Reference Citation Analysis]
355 Poyraz BM, Engin ED, Engin AB, Engin A. The effect of environmental diesel exhaust pollution on SARS-CoV-2 infection: The mechanism of pulmonary ground glass opacity. Environ Toxicol Pharmacol 2021;86:103657. [PMID: 33838330 DOI: 10.1016/j.etap.2021.103657] [Reference Citation Analysis]
356 Shimizu J, Sasaki T, Yamanaka A, Ichihara Y, Koketsu R, Samune Y, Cruz P, Sato K, Tanga N, Yoshimura Y, Murakami A, Yamada M, Itoi K, Nakayama EE, Miyazaki K, Shioda T. The potential of COVID-19 patients' sera to cause antibody-dependent enhancement of infection and IL-6 production. Sci Rep 2021;11:23713. [PMID: 34887501 DOI: 10.1038/s41598-021-03273-0] [Reference Citation Analysis]
357 Soh SM, Kim Y, Kim C, Jang US, Lee HR. The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance. J Microbiol 2021;59:807-18. [PMID: 34449057 DOI: 10.1007/s12275-021-1348-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
358 Hidalgo-Tenorio C, García-Vallecillos C, Sequera-Arquelladas S; COVID-19 Virgen de las Nieves TEAM. Real-world outcomes of COVID-19 treatment with remdesivir in a Spanish hospital. Medicine (Baltimore) 2021;100:e27228. [PMID: 34664862 DOI: 10.1097/MD.0000000000027228] [Reference Citation Analysis]
359 Sarma P, Bhattacharyya A, Kaur H, Prajapat M, Prakash A, Kumar S, Bansal S, Kirubakaran R, Reddy DH, Muktesh G, Kaushal K, Sharma S, Shekhar N, Avti P, Thota P, Medhi B. Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis. Indian J Pharmacol 2020;52:535-50. [PMID: 33666200 DOI: 10.4103/ijp.ijp_1146_20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
360 Gawaz A, Guenova E. Microvascular Skin Manifestations Caused by COVID-19. Hamostaseologie 2021;41:387-96. [PMID: 34695855 DOI: 10.1055/a-1581-6899] [Reference Citation Analysis]
361 Maecker HT. Immune profiling of COVID-19: preliminary findings and implications for the pandemic. J Immunother Cancer 2021;9:e002550. [PMID: 33963016 DOI: 10.1136/jitc-2021-002550] [Reference Citation Analysis]
362 Duret PM, Spielmann L, Messer L. Response to: 'Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina et al. Ann Rheum Dis 2021;80:e80. [PMID: 32816687 DOI: 10.1136/annrheumdis-2020-218147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Keri VC, Hooda A, Kodan P, R L B, Jorwal P, Wig N. Intricate interplay between Covid-19 and cardiovascular diseases. Rev Med Virol 2021;31:e2188. [PMID: 33128859 DOI: 10.1002/rmv.2188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
364 Kazemi S, Pourgholaminejad A, Saberi A. Stroke Associated with SARS-CoV-2 Infection and its Pathogenesis: A Systematic Review. Basic Clin Neurosci 2021;12:569-86. [PMID: 35173912 DOI: 10.32598/bcn.2021.3277.1] [Reference Citation Analysis]
365 Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, Gangula PR, Pandey MK, Durden DL, Byrareddy SN, Challagundla KB. COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges. Theranostics 2021;11:731-53. [PMID: 33391502 DOI: 10.7150/thno.51471] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
366 Rios CI, Cassatt DR, Hollingsworth BA, Satyamitra MM, Tadesse YS, Taliaferro LP, Winters TA, DiCarlo AL. Commonalities Between COVID-19 and Radiation Injury. Radiat Res 2021;195:1-24. [PMID: 33064832 DOI: 10.1667/RADE-20-00188.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
367 Khatiwada S, Subedi A. A Mechanistic Link Between Selenium and Coronavirus Disease 2019 (COVID-19). Curr Nutr Rep 2021;10:125-36. [PMID: 33835432 DOI: 10.1007/s13668-021-00354-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
368 Brake SJ, Eapen MS, Mcalinden KD, Markos J, Haug G, Larby J, Chia C, Hardikar A, Singhera GK, Hackett TL, Lu W, Sohal SS. SARS-CoV-2 (COVID-19) Adhesion Site Protein Upregulation in Small Airways, Type 2 Pneumocytes, and Alveolar Macrophages of Smokers and COPD – Possible Implications for Interstitial Fibrosis. COPD 2022;Volume 17:101-15. [DOI: 10.2147/copd.s329783] [Reference Citation Analysis]
369 Di Gioacchino A, Šulc P, Komarova AV, Greenbaum BD, Monasson R, Cocco S. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2. Mol Biol Evol 2021;38:2428-45. [PMID: 33555346 DOI: 10.1093/molbev/msab036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Prabhahar A, Naidu GSRSNK, Chauhan P, Sekar A, Sharma A, Sharma A, Kumar A, Nada R, Rathi M, Kohli HS, Ramachandran R. ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review. Rheumatol Int. [DOI: 10.1007/s00296-021-05069-x] [Reference Citation Analysis]
371 Dhrisya C, Prasathkumar M, Becky R, Anisha S, Sadhasivam S, Essa MM, Chidambaram SB, Al-Balushi B, Guillemin GJ, Qoronfleh MW. Social and Biological Parameters Involved in Suicide Ideation During the COVID-19 Pandemic: A Narrative Review. Int J Tryptophan Res 2020;13:1178646920978243. [PMID: 35185341 DOI: 10.1177/1178646920978243] [Reference Citation Analysis]
372 Kumar A, Sharma A, Tirpude NV, Sharma S, Padwad YS, Kumar S. Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection. Inflammopharmacol. [DOI: 10.1007/s10787-021-00903-x] [Reference Citation Analysis]
373 Premkumar M, Kedarisetty CK. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. J Clin Transl Hepatol 2021;9:256-64. [PMID: 34007808 DOI: 10.14218/JCTH.2021.00055] [Reference Citation Analysis]
374 Du XQ, Shi LP, Cao WF, Chen ZW, Zuo B, Hu JY. Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Front Pharmacol 2021;12:708636. [PMID: 34603023 DOI: 10.3389/fphar.2021.708636] [Reference Citation Analysis]
375 Marcinkiewicz J, Witkowski JM, Olszanecki R. The dual role of the immune system in the course of COVID-19. The fatal impact of the aging immune system. Cent Eur J Immunol 2021;46:1-9. [PMID: 33897278 DOI: 10.5114/ceji.2021.105240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
376 Robinson-Agramonte MA, Gonçalves CA, Noris-García E, Préndes Rivero N, Brigida AL, Schultz S, Siniscalco D, García García RJ. Impact of SARS-CoV-2 on neuropsychiatric disorders. World J Psychiatr 2021; 11(7): 347-354 [PMID: 34327127 DOI: 10.5498/wjp.v11.i7.347] [Reference Citation Analysis]
377 Park J, Park R, Jang M, Park YI. Therapeutic Potential of EGCG, a Green Tea Polyphenol, for Treatment of Coronavirus Diseases. Life (Basel) 2021;11:197. [PMID: 33806274 DOI: 10.3390/life11030197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
378 Portacci A, Diaferia F, Santomasi C, Dragonieri S, Boniello E, Di Serio F, Carpagnano GE. Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure. Respir Med 2021;187:106556. [PMID: 34375925 DOI: 10.1016/j.rmed.2021.106556] [Reference Citation Analysis]
379 Ghosh A, Sarkar A, Paul P, Patel P. The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19. Fungal Biol Rev 2021;38:67-91. [PMID: 34548877 DOI: 10.1016/j.fbr.2021.09.003] [Reference Citation Analysis]
380 Spanakis M, Patelarou A, Patelarou E, Tzanakis N. Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments. Int J Environ Res Public Health 2021;18:11711. [PMID: 34770225 DOI: 10.3390/ijerph182111711] [Reference Citation Analysis]
381 Timpani CA, Rybalka E. Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19. Pharmaceuticals (Basel) 2020;14:15. [PMID: 33375288 DOI: 10.3390/ph14010015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
382 Rocha J, Basra T, El Kurdi B, Venegas-Borsellino C. Effects of Potential Micro- and Macro-nutrients in Combatting COVID-19. Curr Surg Rep 2021;9:24. [PMID: 34484977 DOI: 10.1007/s40137-021-00301-w] [Reference Citation Analysis]
383 Temerozo JR, Sacramento CQ, Fintelman-Rodrigues N, Pão CRR, de Freitas CS, Dias SSG, Ferreira AC, Mattos M, Soares VC, Teixeira L, Azevedo-Quintanilha IG, Hottz ED, Kurtz P, Bozza FA, Bozza PT, Souza TML, Bou-Habib DC. VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells. J Leukoc Biol 2022. [PMID: 35322471 DOI: 10.1002/JLB.5COVA1121-626R] [Reference Citation Analysis]
384 Aleksova A, Gagno G, Sinagra G, Beltrami AP, Janjusevic M, Ippolito G, Zumla A, Fluca AL, Ferro F. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Int J Mol Sci 2021;22:4526. [PMID: 33926110 DOI: 10.3390/ijms22094526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
385 Noce A, Albanese M, Marrone G, Di Lauro M, Pietroboni Zaitseva A, Palazzetti D, Guerriero C, Paolino A, Pizzenti G, Di Daniele F, Romani A, D'Agostini C, Magrini A, Mercuri NB, Di Daniele N. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients. Pharmaceuticals (Basel) 2021;14:336. [PMID: 33917573 DOI: 10.3390/ph14040336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
386 Hanna R, Dalvi S, Sălăgean T, Pop ID, Bordea IR, Benedicenti S. Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review. J Inflamm Res 2021;14:13-56. [PMID: 33447071 DOI: 10.2147/JIR.S282213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
387 Pooam M, Aguida B, Drahy S, Jourdan N, Ahmad M. Therapeutic application of light and electromagnetic fields to reduce hyper-inflammation triggered by COVID-19. Commun Integr Biol 2021;14:66-77. [PMID: 33995820 DOI: 10.1080/19420889.2021.1911413] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
388 Chegni H, Babaii H, Hassan ZM, Pourshaban M. Immune response and cytokine storm in SARS-CoV-2 infection: Risk factors, ways of control and treatment. Eur J Inflamm 2022;20:1721727X2210989. [DOI: 10.1177/1721727x221098970] [Reference Citation Analysis]
389 Guo Y, Hu K, Li Y, Lu C, Ling K, Cai C, Wang W, Ye D. Targeting TNF-α for COVID-19: Recent Advanced and Controversies. Front Public Health 2022;10:833967. [DOI: 10.3389/fpubh.2022.833967] [Reference Citation Analysis]
390 Sule GA, Aysegul A, Selcan S, Atakan T, Eda OT, Deniz O, Filiz HO, Ozlem MT, Dilek S. Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters. Echocardiography 2021;38:1314-8. [PMID: 34184313 DOI: 10.1111/echo.15146] [Reference Citation Analysis]
391 Siddiqui SS, Dhar C, Sundaramurthy V, Sasmal A, Yu H, Bandala-Sanchez E, Li M, Zhang X, Chen X, Harrison LC, Xu D, Varki A. Sialoglycan recognition is a common connection linking acidosis, zinc, and HMGB1 in sepsis. Proc Natl Acad Sci U S A 2021;118:e2018090118. [PMID: 33658363 DOI: 10.1073/pnas.2018090118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
392 Norooznezhad AH, Mansouri K. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19). Microvasc Res 2021;137:104188. [PMID: 34022205 DOI: 10.1016/j.mvr.2021.104188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
393 Antonov VN, Ignatova GL, Pribytkova OV, Sleptsova SS, Strebkova EA, Khudyakova EA, Simakov AI, Rabets SY, Tikhonova EP, Kurmaeva DY, Petrushin MA, Mashkov AS, Gayazova EV, Yasheva IV, Andreev MA, Khinovker VV, Karpunin AY, Berezhanskiy BV. [Experience of olokizumab use in COVID-19 patients]. Ter Arkh 2020;92:148-54. [PMID: 33720587 DOI: 10.26442/00403660.2020.12.200522] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
394 Sen'kova AV, Savin IA, Brenner EV, Zenkova MA, Markov AV. Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study. PLoS One 2021;16:e0260450. [PMID: 34807957 DOI: 10.1371/journal.pone.0260450] [Reference Citation Analysis]
395 Batista KS, de Albuquerque JG, Vasconcelos MHA, Bezerra MLR, da Silva Barbalho MB, Pinheiro RO, Aquino JS. Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19? Nutr Res Rev 2021;:1-18. [PMID: 34668465 DOI: 10.1017/S0954422421000317] [Reference Citation Analysis]
396 Poutoglidou F, Saitis A, Kouvelas D. Ibuprofen and COVID-19 disease: separating the myths from facts. Expert Rev Respir Med 2021;15:979-83. [PMID: 34196258 DOI: 10.1080/17476348.2021.1951239] [Reference Citation Analysis]
397 Manolis AS, Manolis AA, Manolis TA, Melita H. COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges. J Cardiovasc Pharmacol Ther 2021;26:399-414. [PMID: 33949887 DOI: 10.1177/10742484211011026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
398 Abdelhafiz AS, Fouad MA, Sayed-Ahmed MM, Kamel MM, Ali A, Fouda M, Khalil MA, Abdel-Moneim AS, Kamal LM. Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients. Virology 2021;563:74-81. [PMID: 34478955 DOI: 10.1016/j.virol.2021.08.012] [Reference Citation Analysis]
399 Johansson A, Mohamed MS, Moulin TC, Schiöth HB. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms. J Neuroimmunol 2021;358:577658. [PMID: 34304141 DOI: 10.1016/j.jneuroim.2021.577658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
400 Emanuele S, Celesia A, D'Anneo A, Lauricella M, Carlisi D, De Blasio A, Giuliano M. The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19. Int J Mol Sci 2021;22:7963. [PMID: 34360732 DOI: 10.3390/ijms22157963] [Reference Citation Analysis]
401 Mahroum N, Watad A, Bridgewood C, Mansour M, Nasr A, Hussein A, Khamisy-Farah R, Farah R, Gendelman O, Lidar M, Shoenfeld Y, Amital H, Kong JD, Wu J, Bragazzi NL, McGonagle D. Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic. Int J Environ Res Public Health 2021;18:9149. [PMID: 34501738 DOI: 10.3390/ijerph18179149] [Reference Citation Analysis]
402 Wichniak A, Kania A, Siemiński M, Cubała WJ. Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders. Int J Mol Sci 2021;22:8623. [PMID: 34445329 DOI: 10.3390/ijms22168623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
403 Barone SM, Paul AG, Muehling LM, Lannigan JA, Kwok WW, Turner RB, Woodfolk JA, Irish JM. Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy. Elife 2021;10:e64653. [PMID: 34350827 DOI: 10.7554/eLife.64653] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
404 Shen Y, Anwar TB, Mulchandani A. Current status, advances, challenges and perspectives on biosensors for COVID-19 diagnosis in resource-limited settings. Sensors and Actuators Reports 2021;3:100025. [DOI: 10.1016/j.snr.2021.100025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
405 Kusi KA, Frimpong A, Partey FD, Lamptey H, Amoah LE, Ofori MF. High infectious disease burden as a basis for the observed high frequency of asymptomatic SARS-CoV-2 infections in sub-Saharan Africa. AAS Open Res 2021;4:2. [DOI: 10.12688/aasopenres.13196.1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
406 Kudelko M, Yip TF, Hei Law GC, Lee SMY. Potential Beneficial Effects of Vitamin K in SARS-CoV-2 Induced Vascular Disease? Immuno 2021;1:17-29. [DOI: 10.3390/immuno1010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
407 Cruzado Vega LL, Santos García A. SARS-CoV-2 and Aspergillus pneumonia in kidney transplantation: More frequent than we think? Nefrologia (Engl Ed) 2021:S0211-6995(21)00011-4. [PMID: 33608162 DOI: 10.1016/j.nefro.2020.11.005] [Reference Citation Analysis]
408 Bozorgmehr N, Mashhouri S, Perez Rosero E, Xu L, Shahbaz S, Sligl W, Osman M, Kutsogiannis DJ, MacIntyre E, O'Neil CR, Elahi S. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection. mBio 2021;12:e00384-21. [PMID: 33947753 DOI: 10.1128/mBio.00384-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
409 Hellou E, Mohsin J, Elemy A, Hakim F, Mustafa-Hellou M, Hamoud S. Effect of ArtemiC in patients with COVID-19: A Phase II prospective study. J Cell Mol Med 2022. [PMID: 35587574 DOI: 10.1111/jcmm.17337] [Reference Citation Analysis]
410 Li M, Ching TH, Hipple C, Lopez R, Sahibzada A, Rahman H. Use of Intravenous Vitamin C in Critically Ill Patients With COVID-19 Infection. J Pharm Pract 2021;:8971900211015052. [PMID: 34098784 DOI: 10.1177/08971900211015052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
411 Mardian Y, Kosasih H, Karyana M, Neal A, Lau CY. Review of Current COVID-19 Diagnostics and Opportunities for Further Development. Front Med (Lausanne) 2021;8:615099. [PMID: 34026773 DOI: 10.3389/fmed.2021.615099] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
412 Gabrielli M, Franza L, Esperide A, Gasparrini I, Gasbarrini A, Franceschi F; on behalf of GEMELLI AGAINST COVID 2019. Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy. Vaccines 2022;10:192. [DOI: 10.3390/vaccines10020192] [Reference Citation Analysis]
413 Pelaia C, Calabrese C, Garofalo E, Bruni A, Vatrella A, Pelaia G. Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. Int J Mol Sci 2021;22:3059. [PMID: 33802761 DOI: 10.3390/ijms22063059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
414 Aguida B, Pooam M, Ahmad M, Jourdan N. Infrared light therapy relieves TLR-4 dependent hyper-inflammation of the type induced by COVID-19. Commun Integr Biol 2021;14:200-11. [PMID: 34552685 DOI: 10.1080/19420889.2021.1965718] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
415 Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Organ-specific manifestations of COVID-19 infection. Clin Exp Med 2020;20:493-506. [PMID: 32720223 DOI: 10.1007/s10238-020-00648-x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 102] [Article Influence: 52.5] [Reference Citation Analysis]
416 Petito E, Falcinelli E, Paliani U, Cesari E, Vaudo G, Sebastiano M, Cerotto V, Guglielmini G, Gori F, Malvestiti M, Becattini C, Paciullo F, De Robertis E, Bury L, Lazzarini T, Gresele P; COVIR study investigators. Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019. J Infect Dis 2021;223:933-44. [PMID: 33280009 DOI: 10.1093/infdis/jiaa756] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
417 Arnardottir H, Pawelzik SC, Öhlund Wistbacka U, Artiach G, Hofmann R, Reinholdsson I, Braunschweig F, Tornvall P, Religa D, Bäck M. Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial. Front Physiol 2020;11:624657. [PMID: 33505321 DOI: 10.3389/fphys.2020.624657] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
418 Noris M. The case of complement inhibitors. Adv Biol Regul 2021;81:100822. [PMID: 34454870 DOI: 10.1016/j.jbior.2021.100822] [Reference Citation Analysis]
419 Aslani M, Mortazavi-Jahromi SS, Mirshafiey A. Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs. Int Immunopharmacol 2021;101:108172. [PMID: 34601331 DOI: 10.1016/j.intimp.2021.108172] [Reference Citation Analysis]
420 Xiong W, Lu L, Zhang B, Luo J, Li W, He L, Sander JW, Mu J, Zhu C, Zhou D. Association of consciousness impairment and mortality in people with COVID-19. Acta Neurol Scand 2021;144:251-9. [PMID: 34028792 DOI: 10.1111/ane.13471] [Reference Citation Analysis]
421 Wahbeh MH, Avramopoulos D. Gene-Environment Interactions in Schizophrenia: A Literature Review. Genes (Basel) 2021;12:1850. [PMID: 34946799 DOI: 10.3390/genes12121850] [Reference Citation Analysis]
422 Matta S, Chopra KK, Arora VK. Morbidity and mortality trends of Covid 19 in top 10 countries. Indian J Tuberc 2020;67:S167-72. [PMID: 33308665 DOI: 10.1016/j.ijtb.2020.09.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
423 Liu A, Raja xavier J, Singh Y, Brucker SY, Salker MS. Molecular and Physiological Aspects of SARS-CoV-2 Infection in Women and Pregnancy. Front Glob Womens Health 2022;3:756362. [DOI: 10.3389/fgwh.2022.756362] [Reference Citation Analysis]
424 Rommasi F, Nasiri MJ, Mirsaeidi M. Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features. Mol Cell Biochem 2022. [PMID: 35013850 DOI: 10.1007/s11010-021-04325-9] [Reference Citation Analysis]
425 Azar MM, Shin JJ, Kang I, Landry M. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome. Expert Rev Mol Diagn 2020;20:1087-97. [PMID: 32990479 DOI: 10.1080/14737159.2020.1830760] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
426 Grygiel-Górniak B, Shaikh O, Kumar NN, Hsu SH, Samborski W. Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients. Reumatologia 2021;59:252-9. [PMID: 34538956 DOI: 10.5114/reum.2021.108554] [Reference Citation Analysis]
427 Santiesteban-Lores LE, Amamura TA, da Silva TF, Midon LM, Carneiro MC, Isaac L, Bavia L. A double edged-sword - The Complement System during SARS-CoV-2 infection. Life Sci 2021;272:119245. [PMID: 33609539 DOI: 10.1016/j.lfs.2021.119245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
428 Steckelings UM, Sumners C. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Clin Sci (Lond) 2020;134:2987-3006. [PMID: 33210709 DOI: 10.1042/CS20200922] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
429 Naghashpour M, Ghiassian H, Mobarak S, Adelipour M, Piri M, Seyedtabib M, Golabi S. Profiling serum levels of glutathione reductase and interleukin-10 in positive and negative-PCR COVID-19 outpatients: A comparative study from southwestern Iran. J Med Virol 2021. [PMID: 34800305 DOI: 10.1002/jmv.27464] [Reference Citation Analysis]
430 Almutairi AS, Abunurah H, Hadi Alanazi A, Alenazi F, Nagy H, Saad Almutairi N, Wells M, Alawam A, Alqahtani MM. The immunological response among COVID-19 patients with acute respiratory distress syndrome. J Infect Public Health 2021;14:954-9. [PMID: 34130119 DOI: 10.1016/j.jiph.2021.05.007] [Reference Citation Analysis]
431 Gromov MS, Rogacheva SM, Barulina MA, Reshetnikov AA, Prokhozhev DA, Fomina AY. Analysis of Some Physiological and Biochemical Indices in Patients with Covid-19 Pneumonia Using Mathematical Methods. J Evol Biochem Physiol 2021;57:1394-407. [PMID: 34955552 DOI: 10.1134/S0022093021060181] [Reference Citation Analysis]
432 Karwaciak I, Sałkowska A, Karaś K, Dastych J, Ratajewski M. Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome. Vaccines (Basel) 2021;9:54. [PMID: 33467724 DOI: 10.3390/vaccines9010054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
433 Farkas K, Pigniczki D, Rutka M, Szántó KJ, Resál T, Bor R, Fábián A, Szepes Z, Lázár G, Molnár T. The complex relationship between viruses and inflammatory bowel disease - review and practical advices for the daily clinical decision-making during the SARS-CoV-2 pandemic. Therap Adv Gastroenterol 2021;14:1756284820988198. [PMID: 33953797 DOI: 10.1177/1756284820988198] [Reference Citation Analysis]
434 Akbari N, Ostadrahimi A, Tutunchi H, Pourmoradian S, Farrin N, najafipour F, Soleimanzadeh H, Kafil B, Mobasseri M. Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial. Journal of Trace Elements in Medicine and Biology 2022. [DOI: 10.1016/j.jtemb.2022.126945] [Reference Citation Analysis]
435 Fogante M, Cavagna E, Rinaldi G. Coronary arteries and aortic valve calcifications in COVID-19. Journal of Medical Imaging and Radiation Sciences 2022. [DOI: 10.1016/j.jmir.2022.01.002] [Reference Citation Analysis]
436 Jergović M, Coplen CP, Uhrlaub JL, Nikolich-Žugich J. Immune response to COVID-19 in older adults. J Heart Lung Transplant 2021:S1053-2498(21)02303-2. [PMID: 34140221 DOI: 10.1016/j.healun.2021.04.017] [Reference Citation Analysis]
437 Fedorchenko Y, Zimba O. CYTOKINES AS POTENTIAL MARKERS OF COVID-19 SEVERITY AND OUTCOMES. CAJMHE 2022;3:10-20. [DOI: 10.47316/cajmhe.2022.3.1.01] [Reference Citation Analysis]
438 Ragab D, Salah-Eldin H, Afify M, Soliman W, Badr MH. A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: A case report. J Med Virol 2021;93:1854-6. [PMID: 33107628 DOI: 10.1002/jmv.26630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
439 Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. Conceptions of the pathophysiology of happy hypoxemia in COVID-19. Respir Res 2021;22:12. [PMID: 33419436 DOI: 10.1186/s12931-021-01614-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
440 Li HP, He X, Zhang L, Li CX, Li SQ, Li QY. Therapeutic Agents Rounding Up the Immunopathology of COVID-19. Ther Clin Risk Manag 2021;17:657-68. [PMID: 34234442 DOI: 10.2147/TCRM.S313003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
441 Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17:11-30. [PMID: 33188364 DOI: 10.1038/s41574-020-00435-4] [Cited by in Crossref: 115] [Cited by in F6Publishing: 113] [Article Influence: 57.5] [Reference Citation Analysis]
442 Kunnumakkara AB, Rana V, Parama D, Banik K, Girisa S, Henamayee S, Thakur KK, Dutta U, Garodia P, Gupta SC, Aggarwal BB. COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci 2021;:119201. [PMID: 33607159 DOI: 10.1016/j.lfs.2021.119201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
443 Baindara P, Chakraborty R, Holliday ZM, Mandal SM, Schrum AG. Oral probiotics in coronavirus disease 2019: connecting the gut-lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials. New Microbes New Infect 2021;40:100837. [PMID: 33425362 DOI: 10.1016/j.nmni.2021.100837] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
444 Kotru S, Klimuntowski M, Ridha H, Uddin Z, Askhar AA, Singh G, Howlader MMR. Electrochemical sensing: A prognostic tool in the fight against COVID-19. Trends Analyt Chem 2021;136:116198. [PMID: 33518850 DOI: 10.1016/j.trac.2021.116198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
445 Hamulka J, Jeruszka-Bielak M, Górnicka M, Drywień ME, Zielinska-Pukos MA. Dietary Supplements during COVID-19 Outbreak. Results of Google Trends Analysis Supported by PLifeCOVID-19 Online Studies. Nutrients 2020;13:E54. [PMID: 33375422 DOI: 10.3390/nu13010054] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
446 Puzyrenko A, Felix JC, Ledeboer NA, Sun Y, Rui H, Sheinin Y. Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis. Pathology 2021:S0031-3025(21)00514-6. [PMID: 34836647 DOI: 10.1016/j.pathol.2021.09.005] [Reference Citation Analysis]
447 von Meijenfeldt FA, Havervall S, Adelmeijer J, Lundström A, Rudberg AS, Magnusson M, Mackman N, Thalin C, Lisman T. Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality. Res Pract Thromb Haemost 2021;5:132-41. [PMID: 33537537 DOI: 10.1002/rth2.12462] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
448 Crooke PS 3rd, Tossberg JT, Porter KP, Aune TM. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection. Curr Res Immunol 2021;2:52-9. [PMID: 33969287 DOI: 10.1016/j.crimmu.2021.04.001] [Reference Citation Analysis]
449 Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther 2021;12:192. [PMID: 33736695 DOI: 10.1186/s13287-021-02265-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
450 Chen Y, Zhuang Z, Yang J, Bai L. Screening of Microbial Natural Products and Biological Evaluation of Trichomicin as Potential Anti-Cytokine Storm Agents. Front Pharmacol 2021;12:770910. [PMID: 34955842 DOI: 10.3389/fphar.2021.770910] [Reference Citation Analysis]
451 Acehan S, Gülen M, Isikber C, Kaya A, Unlu N, Ince C, Toptas Firat B, Koksaldi G, Sümbül HE, Satar S. C-reactive protein to albumin ratio is associated with increased risk of mortality in COVID-19 pneumonia patients. Cukurova Medical Journal 2021;46:1449-58. [DOI: 10.17826/cumj.977050] [Reference Citation Analysis]
452 Daneshgar N, Liang P, Michels CJ, Nester CM, Harshman LA, Dai D. Case Report: Clinical and Pathological Findings of a Recurrent C3 Glomerulopathy With Superimposed Membranoproliferative Glomerulonephritis Pattern and Cryoglobulinemia Associated With COVID-19. Front Pediatr 2022;10:827466. [DOI: 10.3389/fped.2022.827466] [Reference Citation Analysis]
453 Henry BM, Benoit SW, Vikse J, Berger BA, Pulvino C, Hoehn J, Rose J, Santos de Oliveira MH, Lippi G, Benoit JL. The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19). Clin Chem Lab Med 2021;59:599-607. [PMID: 33554561 DOI: 10.1515/cclm-2020-1284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
454 Cepon-Robins TJ, Gildner TE. Old friends meet a new foe: A potential role for immune-priming parasites in mitigating COVID-19 morbidity and mortality. Evol Med Public Health 2020;2020:234-48. [PMID: 33235797 DOI: 10.1093/emph/eoaa037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
455 da Silva-neto PV, do Valle VB, Fuzo CA, Fernandes TM, Toro DM, Fraga-silva TFC, Basile PA, de Carvalho JCS, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella SOC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJRD, Feres O, Arruda E, Maruyama SR, Russo EMS, Viana AL, Santos IKFM, Bonato VLD, Cardoso CRB, Tanus-santos JE, Donadi EA, Faccioli LH, Dias-baruffi M, Fernandes APM, Gerlach RF, Sorgi CA; on behalf of the IMMUNOCOVID Study Group. Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress. Biomolecules 2022;12:604. [DOI: 10.3390/biom12050604] [Reference Citation Analysis]
456 Rosalia RA, Ugurov P, Neziri D, Despotovska S, Kostoska E, Veljanovska-Kiridjievska L, Kuzmanov D, Trifunovski A, Popevski D, Villa G, Mitrev Z. Extracorporeal Blood Purification in Moderate and Severe COVID-19 Patients: A Prospective Cohort Study. Blood Purif 2021;:1-10. [PMID: 34126617 DOI: 10.1159/000515627] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
457 Zhao S, Xie T, Shen L, Liu H, Wang L, Ma X, Wu J, Yuan S, Mor G, Liao A. An Immunological Perspective: What Happened to Pregnant Women After Recovering From COVID-19? Front Immunol 2021;12:631044. [PMID: 33613576 DOI: 10.3389/fimmu.2021.631044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Muhamad SA, Ugusman A, Kumar J, Skiba D, Hamid AA, Aminuddin A. COVID-19 and Hypertension: The What, the Why, and the How. Front Physiol 2021;12:665064. [PMID: 34012410 DOI: 10.3389/fphys.2021.665064] [Reference Citation Analysis]
459 Awosanya OD, Dalloul CE, Blosser RJ, Dadwal UC, Carozza M, Boschen K, Klemsz MJ, Johnston NA, Bruzzaniti A, Robinson CM, Srour EF, Kacena MA. Osteoclast-mediated bone loss observed in a COVID-19 mouse model. Bone 2021;154:116227. [PMID: 34607050 DOI: 10.1016/j.bone.2021.116227] [Reference Citation Analysis]
460 Liu BM, Martins TB, Peterson LK, Hill HR. Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review. Cytokine 2021;142:155478. [PMID: 33667962 DOI: 10.1016/j.cyto.2021.155478] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
461 Kariyappa M, Govindarajan V, Kommalur A. Acute Leukoencephalopathy with Restricted Diffusion in an Infant with Severe COVID-19 and Dengue Coinfection Progressing to West Syndrome. J Trop Pediatr 2021;67:fmab026. [PMID: 33998655 DOI: 10.1093/tropej/fmab026] [Reference Citation Analysis]
462 Zipeto D, Palmeira JDF, Argañaraz GA, Argañaraz ER. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19.Front Immunol. 2020;11:576745. [PMID: 33117379 DOI: 10.3389/fimmu.2020.576745] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 22.0] [Reference Citation Analysis]
463 Ebner B, Volz Y, Mumm JN, Stief CG, Magistro G. The COVID-19 pandemic - what have urologists learned? Nat Rev Urol 2022. [PMID: 35418709 DOI: 10.1038/s41585-022-00586-1] [Reference Citation Analysis]
464 Melin AD, Janiak MC, Marrone F 3rd, Arora PS, Higham JP. Comparative ACE2 variation and primate COVID-19 risk. Commun Biol 2020;3:641. [PMID: 33110195 DOI: 10.1038/s42003-020-01370-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 51] [Article Influence: 17.5] [Reference Citation Analysis]
465 Wehbe Z, Hammoud SH, Yassine HM, Fardoun M, El-Yazbi AF, Eid AH. Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality. Front Immunol 2021;12:659339. [PMID: 34025658 DOI: 10.3389/fimmu.2021.659339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
466 Lallana S, Chen A, Requena M, Rubiera M, Sanchez A, Siegler JE, Muchada M. Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19. J Clin Neurosci 2021;88:108-12. [PMID: 33992168 DOI: 10.1016/j.jocn.2021.03.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
467 Mancini L, Americo LM, Pizzolante T, Donati R, Marchetti E. Impact of COVID-19 on Periodontitis and Peri-Implantitis: A Narrative Review. Front Oral Health 2022;3:822824. [DOI: 10.3389/froh.2022.822824] [Reference Citation Analysis]
468 Volino-Souza M, de Oliveira GV, Conte-Junior CA, Alvares TS. Covid-19 Quarantine: Impact of Lifestyle Behaviors Changes on Endothelial Function and Possible Protective Effect of Beetroot Juice. Front Nutr 2020;7:582210. [PMID: 33195371 DOI: 10.3389/fnut.2020.582210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
469 Ayhan SG, Tanacan A, Atalay A, Sinaci S, Tokalioglu EO, Sahin D, Tekin OM. Assessment of fetal Doppler parameters in pregnant women with COVID-19 infection: a prospective case-control study. J Perinat Med 2021;49:697-701. [PMID: 33660492 DOI: 10.1515/jpm-2020-0512] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
470 Alexandris N, Lagoumintzis G, Chasapis CT, Leonidas DD, Papadopoulos GE, Tzartos SJ, Tsatsakis A, Eliopoulos E, Poulas K, Farsalinos K. Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. Toxicol Rep 2021;8:73-83. [PMID: 33425684 DOI: 10.1016/j.toxrep.2020.12.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
471 Khamis F, Memish Z, Bahrani MA, Dowaiki SA, Pandak N, Bolushi ZA, Salmi IA, Al-Zakwani I. Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection. J Infect Public Health 2021;14:759-65. [PMID: 34022734 DOI: 10.1016/j.jiph.2021.03.016] [Cited by in F6Publishing: 2] [Reference Citation Analysis]